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ABSTRACT
A COMPUTATIONAL MODEL OF
THE LINE-1 RETROTRANSPOSON LIFE CYCLE
AND
VISUALIZATION OF METABOLIC NETWORKS IN 3-DIMENSIONS
Michael D. Martin
June 9, 2022
Computational modeling of metabolic reactions and cellular systems is evolving
as a tool for quantitative prediction of metabolic parameters and reaction pathway
analysis. In this work, the basics of computational cell biology are presented as well as a
summary of physical processes within the cell, and the algorithmic methods used to find
time dependent solutions. Protein-protein and enzyme-substrate interactions are
mathematically represented via mass action kinetics to construct sets of linear differential
equations that describe reaction rates and formation of protein complexes. Using mass
action methods, examples of reaction networks and their solutions are presented within
the Virtual Cell simulation package.
A computational model capturing the life cycle of an ancient (typically dormant)
parasitic genetic element called the long interspersed nuclear element type 1 (LINE-1) is
developed and refined. When activated, the proteins encoded by LINE-1 function to

iv

produce copies of itself that are reinserted into the genome. Thus, activation of LINE-1
is associated with genomic instability, tumorigenesis, and cancer. The model tracks the
copy number of LINE-1 associated proteins, mRNA, and DNA under conditions that
simulate carcinogenic insults to the element’s epigenetic silencing mechanisms. Results
show that proliferation of LINE-1 has a distinct threshold as a function of mRNA copy
number and transcription rate. Above the threshold, the retrotransposon copy number
enters a positive feedback loop that allows the cDNA copy number to grow
exponentially. We also found that most of the LINE-1 RNA was degraded via the
RNAase pathway and that neither ORF0 RNAi, nor the sequestration of LINE-1 products
into granules and multivesicular structures, played a significant role in regulating the
retrotransposon’s life cycle.
Most systems in computational cell biology are represented as 2-dimensional
graphs of nodes symbolizing reactions and chemical species. At even moderate
complexity, however, these network maps become difficult to read and understand.
Thus, a Python interface was developed which maps biological networks generated using
the free Virtual Cell simulation package onto an impressive open source 3-D network
visualization system called OpenGraphiti. By interfacing these two packages the
software allows one to view reaction networks and solutions of simulations in a more
intuitive way.
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CHAPTER 1: INTRODUCTION

A. Motivation of Study
The study of biological systems is evolving from a reductionist approach that
examines the components of the cell to a holistic view that seeks to understand how these
pieces interact. We now understand that these chemical components include lipids,
proteins, ribonucleic acid (RNA), deoxyribonucleic acid (DNA) and a host of low
molecular weight metabolic intermediaries. The lipids comprise the cell membrane,
internal organelle membranes, and nano-scale liposomes that are involved in protein
metabolism, lipid metabolism, signaling, and membrane maintenance.

In the

thermodynamic sense the lipid membranes serve to define a system, i.e., separate the cell
from the environment.

The proteins are linear polymers of 22 distinct amino acids.

They act as major structural elements to physically support the cell and manage the
internal organization of major cellular components. Perhaps more importantly, proteins
are the predominant catalyst for most chemical reactions occurring in the cell. RNA is
also a linear polymer that can come in double stranded flavors and is composed of just 4
components, ribonucleic acids. It is used as an intermediary template copied from the
DNA for the creation of proteins, plays a number of roles in the regulation of protein
synthesis, helps to catalyze the synthesis of proteins and has a role in developmental
biology [4]. DNA is a double stranded cousin of RNA and is also a linear polymer of 4
monomers. It is well known as the carrier of biological information, providing the
1

instructions for building each protein in the cell’s arsenal for survival. DNA also carries
with it the information specifying which protein coding sections, i.e., the genes, should be
turned on and off, under what circumstances and at what rates a protein should be
manufactured. Indeed, genes even have modules within them that allow for alternative
splicing of protein coding RNA, allowing a single gene to encode numerous forms of a
protein to be expressed under specific contexts. Further, specific sequences of RNA and
amino acid sequences, known as motifs, (much like an address) direct RNA and proteins
to specific areas within a cell.
The end of reductionist biological research in many ways was marked by the
completion of the human genome project in 2001 which mapped the sequence of all the
bases within human DNA [5].

The technologies developed as a result, and in the

intervening years, have led to progressively more rapid sequencing at much lower cost.
At the time of this writing (2022) the cost has reached the significant challenge of the
$1,000 genome [6] as reported by Illumina Inc.. Recent developments in sequencing
technologies that involve nano-scale pores and electrochemical detection of nucleotide
identity have led to a portable USB based module, the minION from Oxford Nanopore
that further enables portable, inexpensive high-fidelity sequencing [7]. The result is an
explosion of biological data not just from humans but for model organisms such as mice,
nematodes, plants, yeasts, and bacteria. The trend continues with efforts that map cancer
genomes, identify new microbial species, decode the phylogeny of ancient organisms,
and explore the RNA world. With the blueprint of life elucidated, the new challenge has
become one that strives to understand how the parts interact. This more holistic approach
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has come to be known as the omics revolution: genomics, proteomics, metabolomics, etc.
[8, 9]
Mathematical models of such systems will become a critical tool for future
advances in our understanding. Historically such models were compartmentalized (often
in the name of tractability) to small groups of enzymes or specific metabolic pathways
that are expressed at constant levels in the cell, e.g. studying cytoskeletal behavior[10],
glycolysis[11] or the cell cycle [1] and such methods are particularly useful for analysis
of in vitro systems. At the whole cell level, an idealized goal for these models would
allow prediction of a given cell’s behavior under numerous biological conditions
including developmental lifecycle and disease states.

However, such a complete

understanding must encompass the interaction of all the major cellular components:
compartments, proteins, RNA and DNA. For prokaryotic cells without a nucleus, e.g.,
bacteria, this model would include following the organism’s development through cell
division and would allow genetic engineers to explore changes to a genome before
creating the organism. In the case of eukaryotic organisms, a new level of genetic
complexity is added by the tight regulation of gene expression. These differences stem
from modulation of the organization of DNA within the nucleus, binding of transcription
factors and the still poorly understood action of noncoding RNA [12]. Thus, in the case
of the eukaryotes, the ideal model would encompass cell differentiation and signaling that
might in theory predict formation of an entire organism.

B. The State of Computational Cell Biology
Mathematical modeling of these systems has taken a wide variety of approaches;
some seek only to relate the inputs of biologically relevant stimuli to outputs in the form
of concentrations of metabolic species without consideration of the mechanistic details,
3

e.g., Bayesian gene expression networks, while others attempt a higher fidelity
reconstruction of first principles biological reactions between specific proteins and other
bio molecules. As of 2022, one of the highest fidelity, most comprehensive models
predicts phenotype from genotype for the organism Mycoplasma genitalium [13]. This
organism has one of the smallest known genomes with 470 genes encoded by 580,070
base pairs [14]. In the model by Karr et al, a wide variety of mathematical approaches
were utilized depending on the availability of reaction kinetic data and the amenability of
the method to addressing specific cellular functions. This work further exploited the basic
modularity of metabolism to decouple the computational model into sections that, over
time periods of 1 sec, may be considered roughly independent. The resulting modules
were then independently developed and validated using the appropriate algorithm given
the availability of parameters, knowledge of the cellular subsystem and general
functionality. Ultimately, the model was able to predict the life cycle of the bacterium
under a wide variety of growth conditions and numerous metabolic parameters. One
tremendous shortcoming of the effort that was born of necessity is that the bulk of the
model was composed of custom code with manually input parameters requiring a total of
10 person years to assemble. Thus, there is a clear need to develop standardization in
pathway parameters such as reaction constants and interaction networks but also software
that minimizes custom coded models while enabling a multitude of interacting algorithms
[15-18].
In the last two decades, standards for representing biological models have developed
with a clear favorite being the Systems Biology Markup Language (SBML) that
encompasses a mathematical framework for systems of chemical reactions. At the same
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time considerable effort has led to open software packages such as Virtual Cell [19-21],
Cell Designer [22], Tellurium[23], or libRoadRunner[24] intended to provide an
integrated environment for cell biology simulations. These integrated modelling
environments provide a framework for designing problems that are defined by relevant
compartments within cells or even a multitude of cells, the major components such as
proteins or RNA, and a set of reactions among those components. The problem is further
defined by a set of initial conditions, the user chooses the appropriate solvers and
numerical approach, and then the software calculates the dynamical properties of the
system. Generally, such packages seek to minimize custom coding while enabling
simulation of metabolic pathways and other aspects of cell function without the need to
consider the details of the underlying numerical analysis.

Unfortunately, no

computational standard has so far arisen to represent the role of DNA and the rate at
which it is transcribed to RNA. Ideally, the transcription rate of a section of DNA would
reflect the influence of epigenetics, gene promoters, enhancers, and the role of
transcription factors.

C. Summary of this Work
We begin with a survey of the mathematical models and physical principles used to
simulate the behavior of cells at the metabolic level. The principal theory is mass action
kinetics which relates the Gibbs free energy change in a system to the reaction rates for
formation of protein complexes and general elementary chemical reactions. MichaelisMenten kinetics are used for approximating multi-step reactions that are catalyzed by
biological enzymes. We further discuss the case of cooperative binding as found in
multi-state complexes such as hemoglobin which are represented by the Hill equation.

5

Then we discuss the mathematics of adding transport phenomenon such as diffusion and
membrane transport to systems of coupled reactions. A brief survey of other modeling
paradigms is presented such as Bayesian networks, Boolean networks, and flux balance.
Finally, we provide an overview of computational methods found within the Virtual Cell
software to solve various problem classes such as nonspatial, spatial, stochastic, and
deterministic.
Following the computational methods, a discussion of the biological aspects of the
work are presented. We focus specifically on one family of non-protein coding DNA,
what was once categorized as “junk” DNA. While less than 2% of the human genome
encodes for proteins, almost half are derived from genetic elements known as transposons
and are viral-like genomes that have permanently crept into our ancestral DNA. Our
computational efforts are focused specifically on the long interspersed element
transposon, type 1, or LINE-1 that has copied itself some 100,000 times and now
composes an impressive 17% of the total human genome[5]. Such a large copy number,
found in humans and almost all eukaryotes across the evolutionary spectrum, implies that
they must confer some evolutionary advantages[25]. Though there are clues to their roles
in conferring survival fitness, much remains to be learned. Conversely, a significant
amount of evidence implicates the role of Line-1 in major human diseases that include
genomic instability, tumorigenesis, and cancer. When a typically dormant LINE copy is
activated, the two proteins it encodes function to produce copies of itself (along with
other similar genetic elements) that are reinserted into the genome.
In this work, a computational model of the LINE -1 genetic element is presented. The
model encompasses activation of LINE-1 and attempts to explore the copy numbers of
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proteins, RNA, and DNA associated with the activation as a function of time with the
goal of refining understanding of the underlying molecular mechanisms. The results are
used to connect with experiments in the Ramos lab at Texas A&M. In the first model,
the results are non-physical and show that activation of LINE-1 produces an essentially
exponential growth of the associated DNA and protein. From this we conclude that there
are negative feedback mechanisms that are unaccounted for. In the second model we
demonstrate the addition of RNA interference, RNAse, activity and sequestration
pathways leading to stress granules and multivesicular structures associated with
exosome formation. Finally, we present work on visualizing reaction networks from
Virtual Cell in three dimensions via a freeware application, Open Graphiti.
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CHAPTER 2: PHYSICAL PRINCIPLES AND ALGORITHMIC
METHODS USED IN COMPUTATIONAL CELL BIOLOGY
A. Introduction
A wide variety of mathematical approaches have been developed over the years to
simulate the inner workings of the cell for various purposes with varying degrees of
fidelity and computational cost. We begin this chapter with a discussion of the ab initio
physics involved in computational cell biology; principally the thermodynamics and
statistical mechanics of reactions coupled to diffusion. Then approximations and
empirical mathematical models are presented along with methods for exploring systems
with an unknown reaction topology. Next, we delve into algorithmic approaches applied
in various modelling categories such as fully spatial versus compartmental and stochastic
versus deterministic. The chapter is wrapped up with a discussion of software and
development environments for computational cell biology.

B. Mass Action Kinetics
In biology and chemistry, mass action kinetics is the cornerstone method used to
calculate the rate at which elementary chemical reactions occur, protein complexes form
and the rates of enzymatic catalysis. While the mathematics of mass action have a long
history, it was initially developed to describe the rate of elementary reactions and the
equilibrium concentrations between reactants and products; a nice summary of this
history can be found in Voit et al.[26] and in Ferner et al.[27]. The mathematics of the
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formulation relate the free energy difference between the initial and final states of a
reaction to the initial and final species concentrations. Generally, in biochemistry, such
reactions are assumed to occur at constant physiological pH, temperature, and pressure.
The relation further presumes that these are elementary reactions with only one transition
state and no intermediate rate limiting steps.
The relationship between mass action kinetics and biology was very nicely
outlined in a seminal 1952 paper by Alan Turing [28]. Well known as the father of
modern computer science, Turing demonstrated that simple mass action kinetics with
diffusion can be used to explain how a tiger gets its stripes, or more concisely to explain
the origin of different cell types within a simple biological system. Such systems require
only a few signaling molecules, a sink and source for a gradient, and inhibitory feedback
reactions.
Eq. 1 describes an irreversible reaction where species A and B collide and interact
to form a new species, C, with reaction rate constant K+. Application of the mass action

𝐴 + 𝐵 →𝐾+ 𝐶

Eq. 1

principle yields the differential equation illustrated in Equation 2,

𝑑[𝐶]
= 𝐾+ [𝐴][𝐵]
𝑑𝑡

Eq. 2

where the brackets around the variables indicates concentration of the variable. Note that
𝑑[𝐶]
𝑑𝑡

is proportional to the product of collision rate and the probability the energy is above
9

the activation energy for the reaction. Additionally, given that species C is composed of
1 molecule of A and B it must be that the sum of both A and C, and B and C be constant.
Thus, we have two conservation equations.
[𝐴] + [𝐶] = 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 1
[𝐵] + [𝐶] = 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡 2

For the more general case of reversible reactions with forward reaction constant K+ and
reverse reaction constant K-, the reaction equation is shown below.
𝐴 + 𝐵 ↔𝐾+
𝐾− 𝐶

Eq. 3

We can write the following linear differential equations:
𝑑[𝐶]
= 𝐾+ [A][B] − 𝐾− [𝐶]
𝑑𝑡
𝑑[𝐴]
= −𝐾+ [𝐴][𝐵] + 𝐾− [𝐶]
𝑑𝑡
𝑑[𝐵]
= −𝐾+ [𝐴][𝐵] + 𝐾− [𝐶]
𝑑𝑡
To make connection to thermodynamics, one may consider the equilibrium
situation. At equilibrium

𝑑𝐶
𝑑𝑡

= 0 so

[A][B]
[𝐶]

=

𝐾−
𝐾+

= 𝐾𝑒𝑞 = 𝑒

−∆𝐺0
𝑅𝑇

,where ∆𝐺0 is the

standard free energy of the reaction. Further connections between mass action and the
statistics of collisions and probabilities of reactions are well discussed in Gillespie [29].
The more general case where the reaction can be higher order, such as the
formation of dimers or multispecies complexes in a single elementary reaction is depicted
by the reaction equation below[30]. M different reactant species are transformed to a set
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of products by reaction j where the coefficients βi,j and γi,j represent the stoichiometry of
the reactants and products:
𝑀

𝑀

∑ 𝛽𝑖,𝑗 𝑋𝑖 → ∑ 𝛾𝑖,𝑗 𝑋𝑖
𝑖=1

𝑖=1

Under the assumption that the system is well mixed, the above reactions are described by
a system of ordinary differential equations where the concentration of the species Xi is
given by cl:
𝑀

𝑀
𝛽

𝑐𝑖̇ = ∑((𝛾𝑖,𝑗 − 𝛽𝑖,𝑗 ) 𝑘𝑗 ∏ 𝑐𝑙 𝑙𝑗 )
𝑗=1

𝑙=1

Generally, solutions to such sets of non-homogeneous linear differential equations take
the form of sums of exponentials. That is:
∑ 𝐴 𝑒 𝑏𝑡
where most generally the variables A and b may be complex although in the context of
biological systems the solutions will be really valued. Thus, we take the real part of the
general solution to be:
𝑅𝑒(𝐴 𝑒 𝑏𝑡 ) = 𝐴′ 𝑒 𝛼𝑡 cos(𝜀𝑡 + 𝜑)
where A= A’eiφ and b=α+iε [28]. Thus, we see that depending on the value of α,
solutions will be exponentially increasing, constant or exponentially decreasing
oscillations, assuming e is nonzero. Sums of such solutions also look like Fourier series
and can be used to build arbitrary continuous functions. In practice, solutions to systems
of D.E.s representing metabolism in computational biology will be found numerically
and will be addressed later in this document.
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C. Michaelis-Menten Kinetics
A chemical reaction where some molecule catalyzes a reaction without itself
being consumed as occurs with biological enzymes is typically modeled by MichaelisMenten kinetics. The mathematical expression for the concentration as a function of time
for a substrate (S) undergoing a chemical reaction catalyzed by an enzyme (E) to a
product (P) was empirically deduced in 1913. A nice translation from the original
German and an insightful commentary on the original work of Leonor Michaelis and
Maud Menten was published in 2012 [31]. In terms of elementary steps from a mass
action perspective, the catalytic event is represented in two steps by:
𝑘

𝐸 + 𝑆 ↔𝑘1−1 𝐸𝑆 →𝑘2 𝐸 + 𝑃
in which an enzyme, E, binds to a substrate, S, with forward and reverse binding
constants k1 and k-1 forming the enzyme-substrate complex ES which then catalyzes the
formation of some new product, P, at rate of k2. Note that in this treatment, we assume
the reverse reaction, where the product gets converted back to substrate-enzyme complex,
does not occur. The classic, empirical Michaelis-Menten kinetic equation for which
experimental data are frequently available is given as a continuous ordinary differential
equation:
𝑑[𝑃]
𝑑𝑡

=

[𝑆]∙𝑉𝑚𝑎𝑥
[𝑆]+𝐾1

where the brackets indicate the concentration of the species within them, Vmax is the
maximum reaction rate and Km is the substrate concentration at which the product
formation rate is half of the maximum.
The Michaelis-Menten equation above, may be derived from the elementary
reactions of catalysis with mass action kinetics following typically two approaches: the
12

quasi-steady-state and the equilibrium approximation. The equilibrium approximation
assumes that the substrate concentration is in instantaneous equilibrium with the enzymesubstrate complex; whereas the quasi-steady-state assumes the amount of enzymesubstrate complex is constant and that the amount of enzyme is much smaller than the
substrate [32, 33]. As an example, the derivation of the Michaelis-Menten equation in
the equilibrium approximation is presented.
Given the equilibrium approximation, the assumption is that the substrate
concentration is in instantaneous equilibrium with the enzyme-substrate complex. That
is,
[𝐸][𝑆]𝑘1 = 𝑘−1 [𝐸𝑆]

Eq. 4

where the constants k1 and k-1 are the forward and reverse reactions for the formation of
the enzyme-substrate complex. Also, since the amount of enzyme does not change, it is
a conserved quantity in a well-mixed system, [E] + [ES] = [Eo], where [Eo] is the total
amount of enzyme. Eq. 4 can then be written as
[𝐸𝑆] =

[𝑆][𝐸𝑜 ]𝑘1
(𝑘−1 +[𝑆]𝑘1 )

which can be simplified to
[𝐸𝑆] =

[𝑆][𝐸𝑜 ]
(𝐾1 +[𝑆])

where K1 = k-1/k1. Finally, from mass action we know that
𝑑[𝑃]
𝑑𝑡

= [𝐸𝑆]𝑘2

Combining the above 2 equations yields the Michaelis-Menten equation
𝑑[𝑃]
𝑉𝑚𝑎𝑥 [𝑆]
=
𝑑𝑡
(𝐾1 + [𝑆])
where Vmax = [Eo]k2.
13

Figure 1 illustrates an example of an experimentally derived Michaelis-Menten
curve for the rate of mRNA cleavage by an enzyme complex called RISC (RNA induced
silencing complex). These data are used later in this document as part of a larger model.

Figure 1 Example of Michaelis-Menten kinetics from Km=0.0084 µM and Vmax=7.1x10^6 µM/s

D. Cooperative Binding and the Hill Equation
For many types of proteins, binding, or in the case of enzymes, a catalytic event involves
more than one substrate at once that each have an influence on the rate of subsequent
14

reactions. In these cases, the mathematical formalism is modified from the familiar mass
action kinetics, although each step in the co-operative binding model can be viewed as an
elementary reaction subject to mass action. The mathematical formalism for treating this
case is governed by the Hill equation which is just a generalization of Michaelis-Menten
kinetics. The equation is:
𝑑[𝑃]
𝑉𝑚𝑎𝑥 [𝑆]𝑛
=
𝑑𝑡
(𝐾0.5 )𝑛 + [𝑆]𝑛
where d[P]/dt is the rate of product formation, Vmax is the maximum reaction rate, [S] is
the substrate concentration, K0.5 is the substrate concentration that yields half the
maximum reaction rate and n is the unitless Hill coefficient where n > 0 and indicates the

Figure 2 Example of Hill kinetics when n = 4.
degree of cooperativity. For example, n = 2 suggests that two binding sites are found on
the enzyme and must be occupied before the reaction occurs whereas n < 1 is the case
where multiple substrates inhibit the reaction. Examples of such processes include the
cooperative binding of oxygen in hemoglobin and chemical modifications of enzymes

15

such as carboxylation, glycosylation, or phosphorylation. An example of the sigmoidal
behavior of the Hill equation is shown in Figure 2 when n = 4.

E. Diffusion and Other Transport Phenomena
In addition to the thermodynamics of chemical reactions, motion of species within a
model is another important component for realistic modeling of cellular behavior. This is
particularly true when the reactions occur faster than the rate of transport or where
gradients in concentration are to be expected. Within cells, there are several transport
mechanisms that require consideration: diffusion, membrane transport (there are several
types) and active cellular transport on cytoskeletal components.
Diffusion is governed by the diffusion equation with the most general form (for a
single species) given below
𝜕𝜌(𝑟, 𝑡)
= 𝜵⦁[𝐷(𝑟, 𝑡)𝜵𝜌(𝑟, 𝑡)]
𝜕𝑡
where 𝜌 is the density (or concentration) of some material in a medium and D is the
diffusion coefficient of that material in the medium which may be varying in time or
spatially. In practice, however most problems in cell biology assume a constant diffusion
coefficient, thus the governing equation reduces to
𝜕𝜌(𝑟, 𝑡)
= 𝐷𝜵𝟐 𝜌(𝑟, 𝑡)
𝜕𝑡
Of course, within cells there may be hundreds or even thousands of species
simultaneously diffusing while also reacting to be transformed to new species. In this
case, the solution of the reaction-diffusion equation becomes a vector of densities (one
component for each species) and acquires a new term for reactions.
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𝜕𝝆(𝑟, 𝑡)
= 𝑫𝜵𝟐 𝝆(𝑟, 𝑡) + 𝑹 ∙ 𝝆(𝑟, 𝑡)
𝜕𝑡
Now, D is a diagonal matrix of diffusion coefficients and R is a matrix relating reactants
and products local to the point r.
Solutions to such systems are known to produce complex, self-organized patterns.
It is this mathematical treatment that Turing [28] used to demonstrate the origin of spatial
complexity in organisms. Such systems require only a few signaling molecules, a source
and sink for one or more species, a set of feedback reactions, and proper initial
conditions. While the role of these kinetics in development is a bit more complex,
examples of Turing-type self-organized patterns in biology abound. One well known
experimental system explores the processing of simple sugars on an agarose gel in an
open bioreactor [3]. In the system, the cytosolic contents of yeast cells are spread

Figure 3 Glycolytic waves in an experimental system (top) and computational
system (bottom). Bright areas show enhanced concentration of ADP that result
from reaction-diffusion waves[3].
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uniformly over the surface of the gel while the sugar trehalose (which ultimately yields
adenosine diphosphate, ADP) is introduced in various configurations. The ADP has a
positive feedback effect on its own production from ATP that ultimately produces quasiperiodic spatial-temporal variation in concentrations of ADP and ATP. Figure 3
illustrates the ADP concentration waves produced in an experimental glycolytic system,
compared to a computational model produced from a system of 2 differential equations.
It is interesting to note the similarities between these 2-dimensional reaction
diffusion equations and the patterns formed from John Conway’s game of life [34]. In
the game, a 2-dimensional matrix is populated with “living” or “dead” cells and at each
time step, a cell’s state is determined by a set of simple rules that depend on the state of
the 8 nearest neighbor cells. Such systems have been shown to be computationally
complete, also known as Turing complete [35]; a property that is surely found in living
systems.
Interiors of (particularly eukaryotic) cells are subdivided into numerous
compartments that are typically delineated from the cytosol by protein impregnated
phospholipid membranes, see Figure 4. The amphiphilic phospholipids self-organize into
bilayers with their hydrophilic heads facing the aqueous phase and the hydrophobic tails
facing each other. Pure lipid membranes intrinsically prevent transport of most
molecules, polar species and ions but allow diffusion of water and small uncharged
molecules such as nitrogen and oxygen. It is the integral membrane proteins that enable
the motion of impermeable species subject to the needs of the cell and maintenance of
homeostasis.
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Figure 4 A simple structural model of membranes defining the compartments of a cell
[2].
Mass transport through biomembranes can be classified into several crude
categories: passive, facilitated, and active. In the passive case, molecules simply diffuse
down their concentration gradient whereas facilitated transport requires carriers or
channels to allow diffusion through the membrane. Active transport requires energy,
typically in the form of ATP, and can selectively pump species against electrochemical
potentials. Mechanisms for active transport include those enabled by protein pumps,
exocytosis of cargo laden lipid vesicles (nanoscale bags of phospholipids) and the inverse
process of endocytosis where species are captured by invagination of a membrane. In a
certain sense there is a fourth sort of membrane transport, information, where some
stimulus on one side of the membrane is transmitted to the other via some response.
Such systems are commonly used to convey signals from the extracellular environment to
the cytosol. In the case of facilitated, active and information transport through
membranes, the action is often gated by some stimuli. These include ligands such as
proteins or small molecules, voltage, light, membrane curvature, temperature, and
mechanical stress.
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Mathematically, the flux of an electrically neutral molecule between well mixed
compartments through a membrane may be represented by a mass action-like reaction
which states that the flux per unit area, J, of a species is directly proportional to the
gradient of the concentration, c. In one dimension this is sometimes known as Fick’s law
of diffusion:
𝐽 = −𝐷

𝜕𝑐
𝜕𝑥

where D is the diffusion coefficient with units of area per unit time. In the
context of membrane physiology, the above is sometimes simplified to state
𝑑𝑐𝑖
= 𝑓𝑙𝑢𝑥 = −𝑃(𝑐𝑖 − 𝑐𝑒 )
𝑑𝑡
with ci the internal concentration, ce external, and P is known as the permeability
of the membrane. In the models presented in this work, all species that move through
the membrane are treated using this approach. It should be noted that this treatment
applies only for uncharged species and the special case that the diffusion is facilitated by
a constant number of channels or carrier proteins during the simulation as this would
imply a permeability that changes over time.
In addition to motion through membranes, physiologically, proteins and other
molecules move and diffuse within the plane of the membrane following what is known
as the fluid mosaic model. It is not uncommon for membrane proteins to form large
complexes with each other or cofactors in response to some stimulus.
Finally, in addition to diffusion within cells, many molecular species are localized
by the directed trafficking along the nanoscale filaments that compose the highly
dynamic cytoskeleton. Lipid vesicles loaded with cargo use a complex addressing
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system to sort and deliver their contents to the correct location within the cell.

In the

case of proteins, localization occurs in major organelles such as the nucleus,
mitochondria, chloroplasts, endoplasmic reticulum, cilia, and the Golgi apparatus[36].
Many protein localization phenomena occur by localization of the precursor mRNA
along with translational repression until the mRNA is either in the correct location or the
protein product is needed physiologically. This process reduces the metabolic cost of
producing and then localizing proteins until they are needed. As with other forms of
molecular trafficking within the cell, mRNA, often in the form of large
ribonucleoproteins (complexes of RNA and proteins) moves along the cytoskeleton
directed by “Zipcodes” found in the 3’ untranslated portion of the mRNA[37].

F. Other Types of Models - Bayesian, Boolean, and Flux Balance Analysis
So far, the discussion of methods for modelling cellular systems has focused on ab
initio theory that is directly connected to empirical interaction data along with the
thermodynamics and mass transport of chemical reactions. There are several modelling
paradigms that take a more abstract approach and try to account for the paucity of data
concerning either the topology of reactions or reaction kinetics. Here we focus on several
important approaches: Bayesian networks, Boolean networks, and flux balance.
The Bayesian network approach utilizes statistics to link causal relationships along
with a graphical representation to infer relationships amongst variables [38]. The
technique is widely used in machine learning, epidemiology, medical diagnostics, and
may be applied to any problem requiring inference of relationships amongst noisy data.
Within the field of computational cell biology Bayesian techniques are employed to
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determine gene expression patterns[39], genetic changes leading to cancers[40],
exploring protein-protein interaction networks, and to discriminate among competing
interaction models[41].
Bayes theorem can be illustrated as a biological example if one considers a binary
system such as the detection of a transcription factor in a measurement and then a protein
expressed by that transcription factor. Bayes theorem states that the joint probability of
finding the transcription factor and the protein (P(T,P1)) is equal to multiplying the
conditional probabilities to find T given P1, P(T|P1), and the probability of P1, P(P1),
and is further equal to the probability of finding P1 given T multiplied by P(T).
Mathematically this is summarized as:
𝑃(𝑇, 𝑃1) = 𝑃(𝑇|𝑃1)𝑃(𝑃1) = 𝑃(𝑃1|𝑇)𝑃(𝑇)
The more standard form of Bayes theorem is written as:
𝑃(𝑇|𝑃1) =

𝑃(𝑃1|𝑇)𝑃(𝑇)
𝑃(𝑃1)

Where P(T|P1) is the posterior probability, P(T) is the prior probability, P(P1|T) for
a particular value of P1 is known as the likelihood of T given P1, and P(P1) is the prior
probability of P1 and acts as a normalization factor.
Bayesian network analysis links graph theory and Bayes theorem to relate known
(often experimental outcomes) to probabilities of prior statistical states. Joining graph
theory to Bayes theorem can be illustrated by considering the example of a graph that
represents causal relationships between transcription factors (proteins that influence the
production of other proteins) and their target genes. See Figure 5 where “Transcription
Factor 1” and “Transcription Factor 2” influence the production of “Protein 1” and
“Protein 1” is transformed to “Protein 2”, e.g., through a chemical modification.
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Considering the variables to be binary, that T1, T2, P1 and P2 are simply found in the
system or not, we can write the joint probability of finding “Protein 1”, “Protein 2”, and
states T1 and T2 as:
𝑃(𝑃1, 𝑃2, 𝑇1, 𝑇2) = 𝑃(𝑃1|𝑇1, 𝑇2)𝑃(𝑇1)𝑃(𝑇2)𝑃(𝑃2|𝑃1)
In words, the joint probability of P1, P2, T1 and T2 equals the probability of P1 given T1
and T2 multiplied by the probabilities of T1, T2, and P2 given P1.
The above treatment can be extended to include continuous variables and large
networks of interacting elements. In the case of determining the topology of gene
regulatory networks (or other topologies), the Bayesian approach can be extremely
computationally expensive, scaling as n!. Thus in most problems numerical techniques
are applied to make the problems tractable: the variational Bayesian ExpectationMaximization method[42] and Gibbs sampling [43] (a Markov Chain Monte Carlo
method) for example are applied to calculations of posterior probabilities. Other classes
of problems are more readily addressed with Bayesian methods such as choosing between
competing network models based purely on the probabilities of the model[41]. In any
event, the naïve Bayesian network approach suffers from the shortcoming that it is often
applied to gene regulatory networks where the graphs are acyclic, ignoring the very
important feedback mechanisms found throughout biological systems.
Similar to the Bayes networks, in the Boolean network approach genes or proteins
are represented as the nodes of the graph and the interactions are represented as the
edges[44]. However, the nodes have either a 0 or 1 state and are updated in discrete time
steps based on inputs of the parent nodes and specific Boolean function. Generally, the
method is applied to networks with a known (or hypothesized) topology although the
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theory has been extended to include probabilistic treatments and inference of
topology from experimental data[45]. The major advantage to the Boolean treatment is
that large networks can be computationally explored. The major disadvantage is that
such systems are a crude representation of biological systems that often have varying
degrees of protein expression and degradation.

Figure 5 A Bayesian network depicting interactions between transcription factors and
proteins.
Flux balance analysis is widely used to calculate the flow of metabolites through
metabolic networks and as the name implies relies on balancing masses in a reaction
network at equilibrium. Given a known or hypothesized reaction topology, the system is
constrained to balance system wide input and output fluxes[46] with potential further
constraints on minimum and maximum reaction rates. Positive aspects of flux balance
include there is no need for experimental kinetic parameters, and it may be used to
simulate large systems quickly. The limitations of flux balance include an inability to
predict metabolite concentrations, it is only suited to fluxes at steady state, and it does not
account for regulatory effects such as enzyme activation or variation in gene expression
level.
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G. Algorithmic Choices for Mass Action Kinetics
In the following section a discussion of algorithmic methods is presented with a focus
on those needed to address problems formulated with mass action kinetics and treated as
systems of linear differential equations. For the most part, the discussion is software
agnostic however the numerical methods will be limited to those found in the free
metabolic modeling software, Virtual Cell, developed by the University of
Connecticut[47].
Definition of computational models typically requires specifying a list of reactions
that are often visualized as reaction networks that occur within user defined cellular
compartments. The networks may be modeled using a variety of approaches including
stochastic, deterministic, spatial, non-spatial and hybrid stochastic-deterministic [21].
Further, the models may be constructed so that the software, e.g., BioNetGen, can be
employed to automatically generate permutations of individual reactions involving
formation of complexes or a multitude of species[19, 48]. In some cases, however,
defining the entire network of possible reactions before modeling, can result in a
combinatorial explosion of possible states or species causing the network’s size to
become infinite or otherwise intractable. For example, consider the formation of
cytoskeletal polymers from a multitude of protein monomers such as actin. In such cases
the length of the polymer and the number of species it forms during growth are
essentially infinite. Circumventing the potential challenges of simulating such systems
has required treating each species as an agent in a stochastic model that uses the list of
potential reactions to determine the state at subsequent time points. These agent-based
models are known as network-free simulations in Virtual Cell.
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Combinatorial Complexity and BioNetGen
Generally, a cellular modeling effort begins with enumeration of the basic
biochemical species in the system followed by the design of a set of interactions
(typically represented as a graph) that symbolize possible chemical reactions and binding
events between the species. In many cases however, a particular species may undergo
several chemical modifications, e.g., phosphorylation or ubiquitinylation, or bind to a
variety of other species to form multi-subunit complexes. This property of biological
systems can lead to a combinatorial explosion in the types of composite species in the
model leaving the modeler to manually enumerate those species and define all possible
reactions – a task which may be impossible in some circumstances.
To overcome this challenge, a technique known as rule-based modelling was
developed along with software to automate enumeration of species and reactions. While
there are several packages, the tool used within Virtual Cell is called BioNetGen [21] and
allows for the general definition of binding and modification sites along with generalized
reaction rules. Table 1 illustrates both graphical and BioNetGen representations of
molecules with multiple states and binding sites. For example, looking at the last
molecule in the table “Shc(sh3,y~U~P)”, defines a binding site named “sh3” and a
second site “y” (the short abbreviation for the amino acid tyrosine) with two states, “U”
and “P”, which in this case represent either a lack or the presence of a phosphate group.
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Table 1 Example definitions of molecules with multiple states and binding sites in
Virtual Cell
Graphical Representation

BioNetGen Definition

EGF (site)

EGFR (ecd,tmd,y1~U~P,y2~U~P)

Gb2(sh2)

Shc(sh3,y~U~P)

In a second step, the generalized reaction rules are enumerated, one of which is
illustrated in Figure 6.. The reaction shows the EGFR protein phosphorylated at the “y1”
site reacting with the protein “Gb2” to form a dimer by binding at the EGFR “y1” site.
Note that the question marks at the “ecd”, “tmd”, and “y2” sites indicate that the reaction
can occur independent of the states of those sites. Thus, before running the simulation,
BioNetGen will enumerate all the permutations of the reactions, e.g., reactions with “ecd”
bound and no others, reactions with “ecd” and “tmd” bound and “y2” unbound and
unphosphorylated, etc., yielding 24 permutations all with the same reaction kinetics. It is
also possible that a simulation will generate an infinite number of permutations as is the
case of polymer formation. Consider the case where a monomer has two binding sites
and may react to bind with itself at either of the locations. The resulting permutations
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Figure 6 Example of the definition of a generalized reaction rule for BioNetGen within
Virtual Cell.
allow for the monomers to form chains of infinite length requiring eventual truncation or
another approach for the problem to be tractable.

Network Free Simulation

Given that metabolic computational systems can generate a very large or a countably
infinite number of states, the Virtual Cell simulation package includes a network free
simulator known as NFsim to handle such cases[49]. NFsim uses an extension of the
BioNetGen scripting language to define generalized reaction rules, however instead of
enumerating all possible reactions and species, it treats each species in a simulation as an
agent that the rules can act on and modify. Given however that all possible reactions and
species are NOT enumerated, one cannot write down a system of differential equations
that can then be simplified using traditional techniques. Instead, finding solutions utilizes
stochastic methods that convert the rate constants found in the DE treatment from mass
action kinetics to probabilities of a state transition. Solutions to such problems are found
using a rule-based version of Gillespie’s stochastic simulation algorithm[50, 51] and
results in the linear time scaling of large networks whereas the enumerated DE results in
exponential time scaling.
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Numerical Methods in Computational Cell Biology

Next, a broad survey of the computational and numerical methods used in
computational cell biology is provided with an emphasis on those found within Virtual
Cell. The problem classes are divided in to five broad categories: stochastic or
deterministic, spatial vs. non-spatial and hybrid stochastic-deterministic spatial.
The most straightforward system to find numerical solutions for are one dimensional,
well-mixed system governed by mass action kinetics, with only a single compartment
where a compartment refers to a volume within the model such as the cytosol or the
nucleus. This system is governed by a system of ordinary differential equations as
outlined in the section on mass action kinetics[30]; in short the resulting mathematical
treatment yields a system of first order, potentially non-linear DE’s with initial values.
𝑑𝑦
= 𝑓(𝑦, 𝑡) 𝑦(𝑡𝑜 ) = 𝑦𝑜
𝑑𝑡
To solve such systems and many others, a set of libraries known as SUNDIALS
(SUite of Nonlinear and DIfferential/ALgebraic equation Solvers) [52, 53] is used within
Virtual Cell. These solvers were developed at and are maintained by Lawrence
Livermore National Laboratory to enable solving systems on parallel computing
architectures. Solutions to sets of first order differential equations as above are most
often provided by the CVODE solver which provides methods for addressing stiff and
non-stiff systems. Stiff systems are ones that have components whose time constants are
on different scales such as a rapidly varying species’ concentration mixed with a very
slow, downstream, or independent reaction.
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The next level of complexity involves adding a spatial component, changing the
equations to include diffusion, and transforming them to partial differential equations.
Solutions to such systems are found by dividing the geometry into small volumes,
forming a mesh where the time dependent system parameters are calculated. Several
solvers are available to integrate the equations: a fully implicit finite volume method with
a variable time step, a semi-implicit method with a fixed time step that allows for use of
an adaptive mesh, and a semi-implicit finite volume-particle hybrid solver using a fixed
time step and regular mesh.
In some contexts, where the concentration of species is low for example, a system of
chemical reactions is more accurately represented by systems of discrete, stochastic
events instead of by concentrations that vary continuously; after all, the number of
molecules in the system are not continuous. For non-spatial systems, the method of
Gillespie [29, 50, 51, 54, 55] was developed wherein the reaction constants from mass
action kinetics are transformed to probabilities and the species are represented by integer
values. The method was further refined by Gibson and Bruck so that reactions that do
not take place within the span of time to the first reaction receive no updates and is thus
more computationally efficient [56]. Within Virtual Cell, it is the Gibson-Bruck method
and its variants that are implemented for stochastic systems. The various flavors of the
method account for differences between fast and slow reactions and with fixed and
adaptive time steps [57]. A different stochastic algorithm, described as a kinetic Monte
Carlo method, was developed to address problems with combinatorial complexity where
each molecule is treated as an agent upon which reaction rules act to change its state [58,

30

59]. Within Virtual Cell the algorithm is implemented in a package known as NFSim
that was previously discussed [49].
To treat spatial (1-, 2- or 3-dimensional) problems stochastically, a mesh-free Monte
Carlo based method known as Smoldyn is implemented within Virtual Cell [60, 61].
This solver is a Brownian dynamics simulator that uses continuous spatial variables, as
opposed to lattice points in a mesh, to model diffusion, chemical reactions, and
interactions with surfaces. The necessity to track individual point-like particles causes
these models to run slower than their deterministic counterparts, however the lack of a
mesh within the model allows for more complex and realistic geometries. In many
biological systems there is a combination of species that are best represented as stochastic
and deterministic due to their differences in copy number. Consider for example a
system containing a small number of calcium ion channels and pumps within a
membrane surrounding a calcium reservoir – the proteins would be modeled
stochastically and the calcium deterministically. To address such systems, Virtual Cell
implements a hybrid deterministic-stochastic solver that utilizes the semi-implicit PDE
solver for the continuous variables and Smoldyn for stochastic variables[20].
As an example of some of the solution methods, consider a simple system that models
nuclear export using a chaperone molecule. As Figure 7 illustrates, the system starts with
a dimer of molecules Ran and C in the nucleus, RanC_Nuc, that is allowed to diffuse
through the nuclear membrane with a flux constant of 2.0 µm/s and then disassociates in
the cytosol with a forward reaction constant of 1 s-1 and a reverse reaction constant of
1000 (µM*s)-1. The individual components C_Cyt and Ran_Cyt are unable to diffuse
back into the nucleus after disassociation.
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Figure 7 A simple model of nuclear transport using a chaperone molecule to illustrate
different types of modeling approaches

Figure 8 A comparison of non-spatial deterministic and stochastic simulations with the
same initial conditions.
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Using a non-spatial model with the initial conditions set to RanC_Nuc= 4.5x10-4
µM and RanC_Cyt=Ran_Cyt=C_Cyt=0 we compare solutions using the continuous
differential equation and stochastic methods in Figure 8. The discrete nature of the
stochastic system in the bottom graphs of Figure 8 is evident and one can observe
fluctuations in the data.
The same system can be run in fully spatial regimes as well where the geometry
may be defined analytically, from image files, or surface geometry definition files

Figure 9 A 3-dimensional geometry imported into Virtual Cell from confocal
imaging of a single cell. The dimensions of the geometry are 75µm x 75 µm x 25 µm
and the olive region near the center is the nucleus.
(*.STL). In the example simulation shown in Figure 9 from Virtual Cell, a complex
geometry derived directly from confocal microscopy data of an individual cell is added to
the model and separate regions are defined for the nucleus, cytoplasm, and extracellular
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space. Using the same initial conditions as the non-spatial models the system is meshed
into voxels and reaction diffusion dynamics are included.
An example visualizing the concentration of the RanC dimer in the cytosol after
diffusing out of the nucleus for 0.5 seconds is shown in Figure 10. The figure illustrates
the continuous variation in concentration within a z-slice about 6 µm above the base of
the model.

Figure 10 Visualization of diffusion of the RanC complex into the cytosol from the
nucleus. The data shows the concentration at 0.5 seconds into the simulation in a z-slice
about 6µm from the bottom of the model.
The solution to the same nuclear chaperone model run as a spatial stochastic
simulation is illustrated in Figure 11. This time the RanC dimer is represented as
individual particles symbolizing occupation of a voxel by the molecule.
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Figure 11 Visualization of diffusion of the RanC complex into the cytosol from the
nucleus displaying a solution to a spatial stochastic model. The red dots symbolize
individual RanC dimer particles at 7 seconds into the simulation in a z-slice 6 µm above
the bottom of the model.
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CHAPTER 3: THE BIOLOGY OF JUNK DNA
A. Organization and Structure of DNA in the Nucleus
The human genome is well known for its linear organization into 46 strands of
double helices, containing the two sex chromosomes and two copies of the 22 autosomal
chromosomes with one copy from each parent. This geometry is however the first layer
in a hierarchy of organization that manages the more than 2 meters of DNA found within
the tiny space of the nucleus in nearly every cell in our bodies. It is important to point
out that the classical “X” shape conjured to mind when a non-biologist thinks of DNA
and the chromosomes is the state of these molecules only when cells are about to divide.
Indeed, most of the time DNA is in a combination of condensed and non-condensed
states.
Figure 12 illustrates the organization of the eucaryotic (organisms having a
nucleus) genome under nominal circumstance, i.e., when the cell is not dividing. The
linear strands are typically wrapped around a group of proteins known as histones that
together with the DNA are known as nucleosomes. Strands of nucleosomes are
organized into a secondary structure, known as chromatin, like beads on a string.
Although not shown in the figure, under various conditions, the chromatin can be highly
compressed into tightly bound structures that are known as heterochromatin. Conversely
the DNA may be organized into a more open, loosely bound structure known as
euchromatin. Generally, DNA that is actively transcribing RNA from DNA takes the
36

loosely bound, euchromatic form and DNA that is not producing RNA is
heterochromatic. A further structural level is found within the nucleus where the
chromosomes localize within discrete nuclear regions, where frequently the
heterochromatin is located near the interior of the nuclear membrane.

Figure 12 Hierarchy of DNA organization within the eucaryotic cell [62].
This structural organization is intimately related to the careful control of protein
production within cells that ultimately orchestrates the response of cells to their
environment and, in the case of multicellular organisms, includes defining a cell’s
lineage. In the case of humans, control of that lineage defines the ~210 types of cells and
four broad varieties of tissues of which we are composed. This process of playing
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specific genetic programs that are inherited after cell division is known as epigenetics,
meaning “above the genome”. Specifically, these are properties that are inherited from
cell lineages independent of DNA sequence and include both mitotic and miotic cell
division.
At the lowest level of structural organization, we find the linear sequence of the 4
bases - thymine, guanine, cytosine, and adenine - all organized on a backbone of sugars
and phosphate molecules with a complimentary antisense strand forming the classic
double helix. A directionality along the sequence is established by the locations of
covalent links along the sugar backbone. The 3’ end is named after the number 3
location of the sugar ring which links to the number 5 location (5’) of the adjacent sugar.
DNA and RNA are synthesized from the 5’ to 3’ ends of the chain.
In 2001, the rough draft of the human genetic code was completed revealing the
sequence of the 2.91 billion base pairs in the draft assembly[63]. It came as a surprise to
many that the human genome apparently had only 19,116 genes [64] given that the
humble Nematode (Caenorhabditis elegans) has 19,000 [65] and corn (Zea mays) has a
startling 31,552 genes [66]! It has become apparent in the intervening years that the
evident disparity in complexity between humans and organisms with a more rudimentary
body plan was largely the result of a process known as alternative splicing. In complex
organisms, genes are organized in a modular fashion such that the pre-messenger RNA
produced from a gene coding section of DNA has sections that are translated to protein the exons - and sections of the gene that are spliced out of the RNA known as introns.
This modularity allows a single gene to produce many types of context specific proteins
depending on the exons that are retained in the final mature, messenger RNA. An
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estimated 75% of human genes are capable of undergoing alternative splicing, leading to
an enormous increase in the coding potential of the genome[2].
Another surprising finding established by the completion of the human genome
project was that less than 2% of our DNA is translated into proteins. Over half of the
genome is riddled with sections having numerous repetitive sequences while the second,
somewhat less than half of the genome contains unique sequences that for the most part
do not directly code for proteins. Figure 13 illustrates the broad composition of the
human genome. The unique genomic sections on the right side of the figure include the
exons, the introns, RNA involved in synthesis of proteins, gene regulatory sections bound
by proteins and sequences that might be termed the dark matter of the genome. In the last
decade or so, research has illuminated this dark matter, also known as non-coding RNA,
to reveal it has numerous roles such as regulation of developmental programs,
moderating mRNA circulation lifetime, a role in extracellular communication and
perhaps many other functions [4].

Figure 13 The approximate composition of the human genome [2]
In the repetitive regions, an element of which is the subject of this work, we again
find several classes and levels of complexity. For example, the telomeres found at the
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end of the chromosomes are simply long sections of hexameric repeats composed of
AGGGTT sequences that are on the order of 1000’s of base pairs followed by an
overhang of 12-16 G-rich bases [67]. Similarly several million base pairs of tandem
repeats are found at the centromere of the chromosomes [68], i.e. the central region
where pairs are divided during mitosis, and in the chromosomes having short arms, also
known as acrocentric chromosomes[69]. DNA encoding the ribosome components is
particularly concentrated in the short arm of the acrocentric chromosomes where roughly
300 copies are found in each.

Introduction to Transposons
The largest fraction of the noncoding human genome is occupied by the
transposons. Figure 14 enumerates the names and some of the properties of the major
classes of the transposons. This fascinating class of typically non-coding DNA
encompasses the remnants of genes that seem to be the result of ancient viral infections.
These include the DNA transposons which are 3% of the genome, the retrovirus-like
elements also known as long terminal repeats (LTR) 8%, the short interspersed
nucleotide element (SINE) 13%, and the long interspersed nucleotide element (LINE) at
21% [5].
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Figure 14 Classes of transposons in the human genome [5]. The table provides the name
of the element, whether it can move on its own, a schematic of the genetic structure and
presence of specific genes, the length in base pairs (bp) of the individual element, the
number of copies within the genome, and finally the percentage of human genome
occupied by the transposon.
Transposable elements are segments of DNA found in almost all organisms that
are, or once were, capable of moving around in the genome. They are sometimes referred
to as “jumping genes” although this nomenclature is not entirely correct as most varieties
of transposable elements do not encode functional proteins. There are two broad classes:
type 1 require an RNA intermediate and type 2 that cut and paste their DNA [70]. Fully
functional type 1 transposons require and encode a reverse transcriptase that copies RNA
into DNA. These fully functional elements are known as autonomous retrotransposons in
contrast to the typically more numerous incomplete copies that are not autonomous.
These non-autonomous elements may co-opt reverse transcriptase from the autonomous
elements to complete the copy and paste lifecycles. Similarly, complete copies of the
type 2 transposons encode a protein called transposase that is responsible for the cut and
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paste function and once again the same enzyme may also facilitate the movement of
incomplete transposable elements that are not functional independently.
The movement of transposable elements around the genome can introduce several
deleterious effects. The element might for instance land within a gene producing a
mutation that disrupts the corresponding protein. There is significant evidence that some
of these mutations are associated with tumorigenesis and a variety of cancers [71],
although the causal relationship between transposable elements and cancer is yet to be
fully elucidated. If a transposable element lands in a gene promoter region it might also
change the level of protein or non-coding RNA expression having a wide variety of
down-stream effects. In the case of the type 1 transposable elements that produce RNA
reverse transcriptase, it is possible for RNA not associated with the element to be
converted into DNA and then re-incorporated into the genome. When such RNA
originates from mRNA that typically encodes a protein, the new gene copy is known as a
pseudogene.
Transposable elements are what was once considered “junk” DNA and occupy a
large fraction of eukaryotic genomes; nearly 50% of the human genome and in some
plants over 90% are transposable elements. Given that these genes have grown in
number over evolutionary time, they must serve to confer some sort of competitive
advantage to the host organism, otherwise the transposable elements would have
undergone selective pressure. One apparent advantage is that the pseudogenes [72]
produced by transposable elements helps to drive creation of new or modified proteins
and RNA by reshuffling the genome [70]. Further, the high error rate of duplication for
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retrotransposons means that there are frequent 3’ truncations during reverse transcription
that can lead to expansion of the 5’ promoter changing expression of downstream genes.

B. Epigenetics
Before continuing our discussion of noncoding DNA, we first digress to briefly
outline epigenetics, the mechanisms regulating which parts of the genome are translated
to RNA. In defining epigenetics from a developmental point of view Conrad
Waddington [73] in 1942 stated “We certainly need to remember that between genotype
and phenotype, and connecting them to each other, there lies a whole complex of
developmental processes.” While we are still learning what is responsible for the
heritable transcriptional control of genetic programs, many layers of mechanisms have
been revealed. It is well known that protein transcription factors can bind to gene
promoter sites that then affect downstream genes which can produce more copies of the
original promoter thus producing positive feedback on the initial activated gene and
acting as a latching mechanism.

Figure 15 Schematic view of the histones (yellow) and DNA (red) that composes a
nucleosome. [2]
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An equally rich source of epigenetic control is to be found on the nucleosomes,
the wheel-like structure around which strands of DNA are coiled. These nucleosomes are
composed of paired groups of four proteins known as the histones forming an octamer in
each nucleosome. As shown in the Figure 15, the monomers are dubbed H2A, H2B, H3,
and H4 and are composed of two structural motifs, a globular core and a less ordered
histone tail. Each of the histone tails may be covalently modified at specific locations
along the amino acid sequence by phosphorylation, acetylation, methylation, and
ubiquitylation as seen in Figure 16. Each modification is catalyzed by several editor
enzymes such as histone acetyl transferase (HAT), histone deacetylase (HDAC), protein
kinases for addition of phosphates, histone methyl transferase (HMTs), and ubiquitin
ligases, to name a few. It is generally accepted that each of these well-known
modifications affects the behavior or state of the chromatin and is sometimes referred to
as the histone code[74]. These various states of the histones are “read out” by another
group of proteins affecting compaction, location within the nucleus, position of the
nucleosome on the DNA strand, signaling genetic damage, or histone maintenance.
Generally, the histone code seems to be important for solving the topological problems
related to transcriptional control in the crowded environment of the nucleus. In addition
to the complexities of the histone code, there are several varieties of histones H3 and H2
that are specifically involved in processes such as centromere function for cell division,
transcriptional activation, DNA repair and transcriptional repression such as X
chromosome inactivation.
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Perhaps the single most important modulator of post mitotic gene expression is
the methylation of cytosine residues in sequences of cytosine-guanine dinucleotides (CG)
found in the genetic sequence. These CG islands run together in sequences from 1000 to
2000 base pairs long [2] and are frequently called CpG islands to distinguish from base
pairing C and G residues on complimentary DNA strands. The addition of the methyl
group to this residue correlates to repression of downstream genes and the pattern of
methylation change over the course of developmental time. The methylation is believed
to interfere with the binding of transcription factors and promoters laying upstream of
genes, conversely specific DNA binding proteins prefer to adhere to methylated DNA

Figure 16 Covalent modifications found on the histones [2].
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some of which are involved in recruiting further levels of epigenetic repression by
modification of the associated histones [75].
The complimentary nucleotide sequence to CG is GC, thus when DNA strands are
copied these islands of CG groups are preserved on both strands. Further, during mitosis
and meiosis the pattern of methylation is copied from one strand to the newly copied
strand by enzymes known as methyl transferases. This process allows for continuity in
cell identity after division since the methylation state of these CpGs are transferred to
progeny cells. Experiments have shown that the DNA methyl transferases are critical for
healthy development of embryos and dysregulation of DNA methylation is implicated in
several cancers. Given that most of the genome is non-coding, this mechanism is
employed to repress transcription in the centromere and pericentromere where the DNA
is separated during cell division. Further, CpG methylation is critical for repression of
the transposable elements, one of which is the topic of this work.

C. The Long-Interspersed Nucleotide Element

The bulk of this work is focused on the physiological behavior of the LINE-1
retrotransposon. There are an estimated 500,000 copies of the LINE-1 retrotransposon
sequence in the human genome[5]; however, most are damaged with truncations, point
mutations or other defects, leaving roughly 100 full-length LINE-1’s capable of
transposition [76]. The length of human LINE-1 is ~6kB and contains a 5’ untranslated
region (UTR), two non-overlapping open reading frames labeled ORF1 and ORF2,
followed by a 3’ untranslated region that ends with a polyadenylation signal[77]. The 5’
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UTR has an RNA Pol II sense promoter and an antisense promoter[78] that was recently
demonstrated to be translationally active, now dubbed ORF0[79, 80]. ORF1 encodes for
a 40 kDa RNA binding protein and ORF2 encodes for a 150 kDa protein (ORF2p) that
has both endonuclease and reverse transcriptase activity [78, 81, 82]. The ORF2p has a
cysteine rich region that binds to RNA in a non-specific manner[83], which participates
in the process of reverse transcription. Mutations in either of these open reading frames
have demonstrated that they are both necessary for functional retrotransposition[84].
As illustrated in Figure 17, LINE-1 must be transcribed to RNA via RNA
polymerase II, exported from the nucleus to the cytosol, then translated to generate the
proteins ORF1 and ORF2 (ORF1p and ORF2p, respectively). These proteins then bind
to their own RNA or to other RNAs, to form a ribonucleoprotein (RNP). This complex is
then imported back into the nucleus[85], where ORF1p acts as a nuclear chaperone,
although the RNP complex may also access the DNA during cell division [86]. The
ORF2p endonuclease domain then cleaves DNA at a degenerate consensus sequence
(often rich in A/T nucleotides)[71], to leave a 3’ hydroxyl free for use as a primer. The
reverse transcriptase domain of ORF2p synthesizes a complimentary DNA that can be
integrated back into the genome at the cut site[77].
The 5’ antisense promoter produces transcripts at a rate of about 1/8 that of the
sense promoter[87] and yields dsRNA when binding to the complementary strand.
Further, the ORF0 protein (only 71 amino acids long) has been suggested to play a role in
LINE-1 mobility, and its overexpression shown to weakly increase in retrotransposon
activity[79]. Antisense RNAs frequently serve many functions in cellular metabolism; in
plasmids they can be used in copy number control and in phages they can inhibit primer
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formation[88]. Eukaryotes may use small complementary RNAs to manage splicing and
in multicellular organisms antisense RNAs are widely used to manage embryonic
development. They are known to influence chromatin organization and to control
retrotransposon activity by blocking the activity of Reverse Transcriptase or RNase
H.[88]
LINE-1 is activated in the dysregulated genomes of cancer cells, although the
exact relationship between cancer and retrotransposon activity has yet to be fully
elucidated. Cell culture models of cancer have shown that pharmacologic inhibition of
reverse transcriptase reduces proliferation of prostate, melanoma, teratocarcinoma, colon
carcinoma, lung carcinoma, and acute myeloid leukemia cell lines in a dose dependent
manner [71]. Tumor formation and progression may be linked to mechanisms related to
LINE-1 metabolic activity. A carcinogenic insult can disrupt LINE-1 epigenetic
silencing and lead to retrotransposition events that damage the genome or that more
subtly influence tumorigenic progression[71]. For example, the 3’ UTR of LINE-1
mRNA interacts with several micro RNAs and may act either as a source or a sink for
endogenous micro RNAs that can dysregulate cellular metabolism[89-92]. Finally,
retrotransposon proteins, RNA and DNA are found in freely circulating exosomes
(micro-vesicles) generated by tumor cells. Such exosomes may lead to lateral gene
transfer, and this is a potential cancer progression mechanism. Blood-borne exosomes
are being actively investigated as an early-stage cancer biomarker[92-94].
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Figure 17 A simplified mechanism of the LINE-1 lifecycle and some cellular defense
mechanisms.

D. LINE-1 Regulation

Given LINE-1’s propensity to disrupt genomes, the expression of these elements
is regulated at several levels in tissue- and context-specific manners. At the epigenetic
level, methylation of DNA CpG islands, histone acetylation and histone methylation are
prominent. In the male germline, LINE-1 is inhibited by an elaborate system that
includes PIWI-interacting RNAs (piRNA) leading to methylation of LINE-1 CpG
sequences[71],[95], and related PIWI proteins for piRNA production. It is noteworthy
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that this secondary system of gene silencing is necessary in the germline, as typically
DNA methylation is stripped during formation of primordial germ cells[75].
In addition to epigenetic mechanisms for regulating the transcription of LINE-1,
cells have a host of other tactics for managing LINE-1 mRNA activity. In a recent
review, over 100 proteins were described to interact with LINE-1 RNPs[86]; some of
these are summarized in Table 2. As with other cellular RNAs, the action of RNases are
principal degradation pathways for LINE-1 mRNA. In addition to the general
degradation due to cellular RNase, RNase L (latent) is involved in an interferon-regulated
pathway that responds to RNA and DNA viruses and has been shown to limit
retrotransposition of LINE-1 in cell culture[96]. Similarly, RNase H2, localized to the
nucleus, seems to play a role in LINE-1 RNA degradation of DNA:RNA duplexes[97,
98] . Innate cell defenses such as autophagy, the process of self-eating that utilizes
special compartments known as lysosomes, are also implicated in the degradation of
LINE-1 RNA. A different set of mechanisms are used to modulate the action of LINE-1
ribonucleoprotein particles (RNPs) that involve their localization in cytoplasmic stress
granules[99]. These particles are associated with a cellular stress response where RNPs
and mRNAs are degraded. A protein known as SAMHD1 and an RNA helicase,
MOV10, potentially complexed with a zinc-finger antiviral protein ZAP, associate with
the LINE-1 RNP localized in granules [77, 94]. A remaining open question is whether
the localization of LINE-1 components in the cytoplasm is a necessary event in their “life
cycle” as found in the yeast Ty3 retrotransposon[100] or a result of cellular defenses.
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Table 2 Pathways used to manage epigenetic silencing and post-transcriptional
components of LINE-1.
Pathway

Proteins

Compartment

Cell Type/Context

Description

RNase

RNase L, RNase H2,

Cytoplasm,

Demonstrated in human ovarian

Cleavage of mRNAs

other cellular RNases

Nucleus

cancer cells, HeLa, HEK 293T

from dsRNA[96] and

and SW982 cells

RNA:DNA duplexes[97]

All

Known to be generated

RNAi

Dicer, Exportin, RISC

Cytoplasm

(contains Argonaute,

by sense and antisense

others and siRNA)

transcripts, as found in
LINE-1. Plays a role in
maintaining methylation
H3k9me3[101-103]

Granule

MOV10, ZAP26,

Cytoplasm,

All

General pathways

Localization

SAMHD1[104]

stress granules

involving localization of

and multi-

LINE-1 proteins, RNAs,

vesicular bodies

and DNA in stress
granules and
multivesicular
bodies[99]. Pathway
involved in degradation,
exosome formation and
potentially processing
bodies[104].

PIWI

DNMT3L, PIWIL1,

Nucleus,

Neoplasms, male germ line[71].

Leads to methylation of

Interacting

PIWIL2, PIWIL4[95]

cytoplasm

Demonstrated to play a role in

genomic LINE-1,

RNAs

(aka murine MIWI2)

HBEC LINE-1 propagation[105]

members of the

(piRNAs)

Argonaute family
requires piRNA as a
guide RNA.

apolipoprot

APOBEC3A,

ein B

APOBEC3B and

Nucleus

All, studies in HeLA

Inhibits reverse
transcriptase (eg. Vif-
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mRNA

APOBEC3C[106]

deficient HIV-1 viruses

editing

[104, 107]

are suppressed), Cytidine

enzyme[71]

deaminase that converts
dC to dU on forming
DNA minus strands
during reverse
transcription.

RNA interference (RNAi) mechanisms may play a role in post-transcriptional
degradation of LINE-1 RNA[87], and its epigenetic silencing. RNAi targets double
stranded RNA; the double strand may be formed by mRNA transcribed from the ORF0
antisense promoter[103] within the 5’ UTR of LINE-1[87] binding to LINE-1 mRNA,
although recent evidence suggests that overexpression of ORF0 leads to a modest
increase in LINE-1 mobility[79, 80]. Double stranded RNA (without a hairpin in this
case) is exported from the nucleus and targeted by the enzyme Dicer to form 22
nucleotide siRNAs[4, 108]. Then a helicase separates the two complementary strands of
the siRNA, one of which is subsequently loaded into the RNA induced silencing complex
(RISC) that includes the Argonaute and Slicer proteins. There is further evidence that
RNAi related pathways are critical to the maintenance of heterochromatin (condensed
chromatin) structure in genomic regions containing transposons and repetitive
elements[109]. Currently, it is not clear what the relative roles of these two RNAi
pathways are on LINE-1 management[101] .
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Finally, the cell may target the reverse-transcribed complementary DNA
(cDNA) for degradation. The APOBEC3 enzyme catalyzes conversion of cytosine in
DNA to uracil via deamination (and evidently oxidation) and may then enable
degradation via endonuclease activity[110-112]. Further, the cDNA can be directly
degraded via the endonucleases TREX1 and ERCC1/XPF.[77]

Figure 18 Time dependence of LINE-1 mRNA accumulation in human embryonic
endothelial cells after being challenged with 0.1 µM BaP versus a control of DMSO. The
top of the figure shows Western blot analysis illustrating the presence of ORF1p and
ORF2p at the 12 hour mark. [105]
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Experimentally, the dynamics of LINE-1 has been explored by introducing the
cigarette smoke carcinogen Benzo(a)pyrene (BaP) to cells in culture and subsequently
monitoring LINE-1 mRNA for Orf1 and Orf2 mRNA. Figure 18. shows data from one
study utilizing human bronchial epithelial cells (HBEC), the time course of LINE-1
activation was shown to peak at 12 hours and return to base line after 48 hours upon
exposure to 0.1 BaP [105]. In a separate study, the time course of LINE-1 mRNA was
quantitated with RT-PCR in HeLa cells after exposure to 3 µM BaP, see Figure 1 in
Rempala et al[113]. Illustrated in Figure 19, the LINE-1 mRNA rises from 5.24 AU to a
near constant level of ~11 AU after 3 hours and remains roughly constant until the end of
the experiment at 96 hours.

Figure 19 The time course of LINE-1 mRNA after exposure the 3 µm Bap in HeLa
cells.[113]
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CHAPTER 4: COMPUTATIONAL MODELING OF RNASE,
ANTISENSE ORF0 RNA, AND INTRACELLULAR
COMPARTMENTATION AND THEIR IMPACT ON THE LIFE CYCLE
OF THE LINE RETROTRANSPOSON

A. Summary
When epigenetic silencing mechanisms of LINE-1 fail, the proteins encoded by
LINE-1 engage in reverse transcription to make new copies of their own or other DNAs
that are pasted back into the genome. To elucidate how LINE-1 is dysregulated because
of carcinogen exposure during cancer progression, we developed a computational model
of key elements in the LINE-1 lifecycle, namely, the role of cytosolic ribonuclease
(RNase), RNA interference (RNAi) by the antisense ORF0 RNA, and sequestration of
LINE-1 products into stress granules and multivesicular structures.
The model showed that when carcinogen exposure is represented as either a sudden
increase in LINE-1 mRNA count, or as an increase in mRNA transcription rate, the
retrotransposon copy number exhibits a distinct threshold behavior above which LINE-1
enters a positive feedback loop that allows the cDNA copy number to grow
exponentially. We also found that most of the LINE-1 RNA was degraded via the
RNAase pathway and that neither ORF0 RNAi, nor the sequestration of LINE-1 products
into granules and multivesicular structures, played a significant role in regulating the
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retrotransposon’s life cycle. Several aspects of the prediction agree with experimental
results and indicate that the model has significant potential to inform future experiments
related to LINE-1 activation.

B. Previous Simulations
Previous simulations of LINE-1 activation by Rempala et al.[113, 114] focused
on the steady state solutions of relatively simple systems. These included reactions
involving the creation of LINE-1 mRNA from the corresponding DNA, the formation of
a single protein from the mRNA and the creation of complementary DNA. While both
continuous and stochastic models were explored, the highly simplified architecture of the
model was a shortcoming of the work. Other explorations of the RNAi machinery have
demonstrated that complex behavior emerges due to feed forward and backward loops
between miRNA and their targets, even for relatively simple systems, thus making
computational models particularly critical for exploring these complexities[115].

C. Goals of the Present Simulation
A principal goal for the present study was to examine the relative roles of various
novel mechanisms for LINE-1 post-transcriptional regulatory control, particularly within
the context of cancer cells where LINE-1 is dysregulated. A model was designed to gain
additional insight into the dynamics of LINE-1 components such as mRNA, ORF0
mRNA, and ORF1 and ORF2 proteins. The simulation specifically explored how the
positive feedback loop inherent to LINE-1 interacts with general cytoplasmic RNase
activity, RNA interference pathways, and processes involved in sequestration of LINE-1
into stress granules and multi-vesicular bodies associated with exosome formation. Such
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a model facilitates direct comparison to experiments where carcinogens such as BaP are
introduced into cells in culture to monitor the time evolution of LINE-1 products. Acute
exposure to the carcinogen has been demonstrated to effectively disrupt epigenetic
silencing of LINE-1 resulting in transient expression[116, 117]. Finally, it was our intent
to prepare an open model that provides a starting point for enumerating the regulatory
mechanisms involved with LINE-1. It is important to note that the model does not
include the role of epigenetic silencing, the activity of deaminases such as APOBEC, the
piRNA pathway, or the role of the ORF0 protein in affecting transposition efficiency.

D. Model Components and Framework
Models were created within the free Virtual Cell package developed by the
University of Connecticut[47] and available via the application from a shared model
database. The modeling environment readily enables the creation of reaction networks
that occur within user defined cellular compartments. The networks may be modeled
using a variety of algorithms including continuous (differential equation based),
stochastic, and network free approaches[21]. Further, the models may be constructed so
that BioNetGen can be employed to automatically generate permutations of individual
reactions that involve formation of complexes or a multitude of species[19, 48]. This
allows, for example, formation of polymers such as actin, or accounting for cases where a
large variety of proteins may be degraded by a single protease. Only models that are fully
expressed as mass action kinetics are currently compatible with BioNetGen and the
agent-based network-free algorithms. The Virtual Cell environment also enables
integration of fully spatial models that can include full Monte Carlo representations.
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In this work, only non-spatial models were used with transport between
compartments occurring via a simple mass action reaction. Thus, the system is assumed
to be well-mixed and does not incorporate diffusion of molecules. Given that the number
of molecules, e.g., “Hot” LINE-1 DNA copies or LINE-1 mRNAs, may be <100 at
different time points, stochastic simulations were deemed to be more appropriate than
continuous simulations. Solutions for stochastic problems were found using the GibsonBruck algorithm[56] that converts reaction constants to probabilities and is a refinement
of Gillespie’s methodology[54]. However, due to limitations in stochastic modeling
within Virtual Cell, the full system of reactions must be written in terms of elementary
mass action, as opposed to more sophisticated reaction models such as Michaelis-Menten
or cooperative Hill binding, though these may be converted to mass action expressions.
The present model was initially constructed from three separate components: a
representation of the LINE-1 life cycle, RNA interference, and an approximation of
pathways involving proteins responsible for cytosolic RNA sequestration into stress
granules and pre-exosomal multi-vesicular bodies. Each system was computationally
explored, and in the case of Dicer with the RNA-induced silencing complex (RISC) from
the RNAi pathway, the kinetics matched to experimentally derived rates. The constants
used in the models are provided as supplementary information.
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Figure 20 Illustration of the RNAi reaction pathway used to represent the degradation of
perfectly complementary dsRNA generated by LINE-1 ORF0 RNA (or other fully
complementary RNA) and LINE-1 mRNA. The blue circles are reactants and product
species, the yellow squares are reactions and the arrows dictate the direction of the
reaction.

E. RNA Interference Model
Figure 20 illustrates the RNA interference sub-model containing only seven
unique molecules. The blue circles symbolize reaction species, and the yellow squares
symbolize reactions. In the top left of the figure, mRNA (denoted as mRNA_Nuc) is
exported from the nucleus via mass action (although a chaperone mechanism was also
explored) to the cytosol where it may then be incorporated into RISC primed with a
complementary ssRNA. In the figure, the complex formation is symbolized by the
reaction of mRNA_Cyt with RISC_ssRNA to form RISC_mRNA. The values for the
Michaelis-Menten RISC kinetics were taken from Haley et al[118] and are valid for a
RISC complex with a fully complementary siRNA loaded, although it should be noted
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that there is evidence suggesting that the kinetics may be specific to the guide RNA. In
the nucleus, dsRNA (dsRNA_nuc) in the center left of the figure, representing LINE-1
mRNA complexed with the antisense ORF0 mRNA, is ferried from the nucleus with the
Exportin protein[103, 108] (dsRNA_Exp_Complex in Figure 20). The dsRNA
disassociates from Exportin after arriving in the cytoplasm, the Exportin reenters the
nucleus, while the dsRNA (dsRNA_cyt) may get loaded into the Dicer enzyme. In the
model, Dicer represents the human Dicer1 enzyme found in the cytosol which is an
RNAse that cuts pre-miRNA and dsRNA to lengths of 20 to 25 nt leading to the
formation of single stranded, small interfering RNA’s (siRNA’s). It is noteworthy that
the rates of cleavage are 100x higher for pre-miRNA containing a hairpin structure[119]
versus those formed out of perfectly complementary dsRNA. We chose to use kinetics
associated with fully complementary dsRNA without a hairpin[119], as would be
expected for LINE-1 mRNA complexed with its perfectly complimentary anti-sense Orf0
RNA. The output of Dicer, denoted ssRNA in Figure 20, is loaded into the RISC enzyme
which catalyzes the cleavage of target mRNA that is complementary to the guide
siRNA[118]. There is some evidence that versions of this complex also incorporate into
MOV10, a protein implicated in RNA sequestration. Note that the Drosha enzyme is not
represented in the model as it is specialized to the initial step of the RNA interference
pathway and specific for stem-loop structured RNA [see Genecard entry].
The Michaelis-Menten kinetics for Dicer and RISC were converted to elementary
reactions with mass action kinetics to enable stochastic models in the Virtual Cell [26,
31]. That is, the reaction:
𝑘

𝐸 + 𝑆 ↔𝑘1−1 𝐸𝑆 →𝑘2 𝐸 + 𝑃
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in which an enzyme, E, binds to a substrate, S, with forward and reverse binding
constants k1 and k -1 forming the enzyme-substrate complex ES which then catalyzes the
formation of some new product, P. The classic Michaelis-Menten kinetic equation for
which experimental data are frequently available and which can be modeled only as a
continuous ordinary differential equation in Virtual Cell is given by
𝑑[𝑃] [𝑆] ∙ 𝑉𝑚𝑎𝑥
=
[𝑆] + 𝐾𝑚
𝑑𝑡
wherein [S] is the concentration of substrate and [P] is the product concentration.
The conversion to a math model for enzymes with mass action kinetics typically
follows the equilibrium approximation as the catalyzation to the product (P) with
constant k2 is much slower than the k1 reaction as outlined on Chapter 2. For purposes of
converting the model’s enzymatic reactions from Michaelis-Menten to mass action
kinetics
𝑘2 =

𝑉𝑚𝑎𝑥

Eq. 5

𝐸𝑡

and
𝑘−1 = 𝑘1 ∙ 𝐾𝑚

Eq. 6

where we choose an arbitrary k1 and scale k-1 by Km, specifically k1 was set to 10 (µM*s)1

for both Dicer and RISC. As shown in Eq. 6, only the ratio k-1/k1 have an impact on the

kinetics of the reaction. This is further demonstrated in the tab labelled “Mass Action
Dicer” in the supplemental spreadsheet from Martin et. al. [120] where we simulated the
reaction velocity curves for k1= 10 (µM*s)-1 and 100 (µM*s)-1 using an appropriately
scaled k-1; the data are identical.
Validation of the model against experimental data is given in the supplementary
spreadsheet of Martin et. al. [120]. In the sheet titled “Michaelis-Menten Dicer” we first
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validated a continuous Michaelis-Menten Virtual Cell model for the action of DICER
alone against the experimental data found in Chakravarthy et al [119]. Then the model
was converted to a stochastic-competent, mass action representation and verified. The
data are shown in the sheet titled “Mass Action Dicer”. Similarly, a model was created
for the RISC complex cleaving perfectly complimentary mRNA and compared to
experimental data from Haley and Zamore in the sheets titled “RISC ssRNA MichaelisMenten” and “RISC ssRNA Mass Action”. In each case, the simulated data matched the
empirical literature curves.

F. Exosome and Stress Granule Model
This portion of the model is intended to capture a simplified pathway reflecting
the dynamics of stress granule and exosome formation following LINE-1 activation.
Figure 21 illustrates the basic topology of the reaction network. In this model, the
mediating localization protein is labeled “MOV10” and is used as a gross simplification
of a multitude of pathways that may include ZAP, MOV10, or SMAHD1. This is only a
guess in as much as considerable information is yet to be learned about the details of
localization in “processing bodies”, stress granules and exosomes[104]. The idealization,
however, serves as a starting point for building future model topology in this emerging
area of research.
As with the RNAi portion of the model, we first modeled the pathway
independent of the larger LINE-1 model. In this model there are only 2 molecules: RNA
and MOV10_ZAP and 3 compartments labeled: Cytoplasm, MultiVesicularBodies, and
Stress_Granule. The RNA represents endogenous retrotransposon RNA (although many
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of these localization proteins also act on exogenous viral RNA[104]) and MOV10_ZAP
is used as a simplified place-holder for the proteins involved in localization to the two
compartments within the cytoplasm. The compartment labeled “MultiVesicularBodies”
represents a large group of these precursors to exosome formation and the
“Stress_Granule” represents structures that are involved in RNP sequestration and
degradation. In the full model, this pathway is used for localization of LINE-1
ribonucleoprotein particles to these compartments.

Figure 21 Basic model of stress granule and exosome formation related to exogenous
RNA or retrotransposons.

The stand-alone sequestration model was run with 100,000 and 300,000 initial
RNA molecules to explore the basic dynamics of the system. Graphs of the results and
the raw data are presented as supplemental information in the spreadsheets labeled
“Exosome Proc Bodies 100k RNA” and “Exosome Proc Bodies 300k RNA” from Martin
et. al. [120]. In both cases, only a small fraction of the RNA molecules end up in the
“MultiVesicularBodies” or “Stress_Granule” compartments; only 2.4% of the RNA is
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sequestered into either of these compartments and 95.3% is degraded by background
RNase activity in the cytoplasm.

G. LINE-1 Life Cycle Model
Figure 22 illustrates a simplified model of the LINE-1 lifecycle used in this work.
Starting in the top left of the diagram, upon dysregulation, “Line-1DNA” may generate
“Line1_mRNA” but it may also generate the antisense “Orf0_mRNA”. Following ORF0
mRNA generation, it may complex with the complementary sense LINE-1 mRNA to
form a double stranded complex, “L1mRNA_Orf0_CPLX”, that is subsequently exported
from the nucleus and degraded by RNAi mechanisms in the cytosol (bottom of Figure
22). Similarly, “Line1mRNA” may be degraded by general cytosolic RNase activity
after nuclear export, or it may be translated into the ORF1 and ORF2 proteins. These
proteins subsequently bind to the LINE-1 mRNA, “Line1mRNA_Cyt”, to form a RNP
that is imported back into the nucleus, “L1mRNA_Orf1p_Orf2p_Nuc” in the center
bottom of the figure. In the model, LINE-1mRNA can only reenter the nucleus if it has
at least 1 ORF2p and at least 1 ORF1p. The LINE-1 RNP can then reverse transcribe the
LINE-1mRNA to produce a new copy of “Line1DNA”, essentially closing the life cycle
of the genetic element. Afterwards, the ORF1 and ORF2 proteins are exported back to
the cytoplasm to participate in another round of retrotransposition or be degraded; see top
right of Figure 22. Given that the ORF2 reverse transcriptase lacks RNase H activity[83,
121], the mRNA is preserved and may be re-exported to the cytosol where it may once
again participate in RNP formation and production of new LINE-1 DNA. The
assumption that the freshly reverse transcribed mRNA does not interact with ORF1p and
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ORF2p within the nucleus is based on the observation that neither protein tends to
localize in the nucleus[99, 122]. The model only reflects the formation of new fully
functional DNA copies of the LINE-1 element when many reverse transcribed copies are
not complete.
Generally this model shows exponential growth of LINE-1 DNA copies as a
function of time, in agreement with previous simulations[113].

Figure 22 A simplified visualization of the LINE-1 life cycle model.

H. Full Model Description
Each of the three submodels were combined using a mass action kinetic approach
to maintain compatibility of stochastic simulations within the Virtual Cell environment.
Figure 23 illustrates the reaction network for the merged model. The yellow squares in
the figure symbolize reaction rules and the ellipses with colored circles represent
molecular species. The blue circles at the bottom of the figure are species in the model
that are used to specify initial conditions for purposes of BioNetGen and Network Free
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simulation. The model contains a total of 13 different molecule types and 36 reaction
rules, shown in Figures 2S and Table 1S, respectively of Martin et al. [120]. In the full
stochastic competent model, the molecules have specific binding sites that account for the
formation of protein complexes. Of import is the LINE-1 mRNA that, as a simplifying
approximation, contains only 4 binding sites: 2 for ORF1p, one for ORF2p, and a site for
ORF0 mRNA binding. The approximation that a maximum of only 2 Orf1 proteins bind
to a LINE-1 mRNA is made here to simplify the potential permutations of LINE-1
mRNA states. Experimental evidence suggests that ORF1p forms a homotrimer that then
coats the LINE-1 mRNA in a multitude of copies.[123]

Figure 23 Reaction diagram of a fully integrated model. The ellipses with colored
circles represent reactants and products that may be molecular complexes and have
internal states. As before, the yellow squares represent reactions and the blue circles at
the bottom of the diagram are species definitions used for setting initial conditions. A
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higher resolution image is provided in the supplemental information of Martin et.al. [120]
as Figure 1S.
BioNetGen was used to calculate all the permutations of reactions that may be
possible with multistate molecules based on the defined reaction rules. An example of a
reaction rule definition from the model is depicted in Figure 24, where LINE-1mRNA is
complexed with an ORF2p and two ORF1p proteins but is NOT complexed with an
ORF0 mRNA. The complex undergoes an irreversible reaction to catalyze a new LINE-1
DNA copy after which the RNP completely disassociates.
Given that ORF1p and ORF2p do not localize in the nucleus experimentally, our
model posits that these two proteins will complex with LINE-1 mRNA only in the
cytosol, as opposed to complexing with newly transcribed LINE-1 mRNA in the nucleus
after finishing a round of reverse transcription. Reactions involving the degradation of
ORF1p and ORF2p are assumed to take place in the cytoplasm or in stress granules (as
passengers on LINE-1mRNA) as these proteins are generally not found in the nucleus.
Similarly, LINE-1mRNA degradation within the model occurs in the cytoplasm through a
general background RNase reaction or inside the stress granules. This assumption was
made as the reverse transcriptase in ORF2p does not have RNase H activity, although
there is evidence that endogenous RNase H2 plays a role in nuclear LINE-1 mRNA
degradation[97]. The MOV10_Zap protein may interact with the LINE-1mRNA that has
occupied ORF1p and ORF2p sites, as it complexes via the ORF0 mRNA site.
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Figure 24 Example visualization of a reaction rule where reverse transcription of LINE1mRNA that was complexed with an ORF2p and 2 ORF1p proteins catalyzes a new copy
of LINE-1 DNA. After the reaction, the constituents completely disassociate.

I. Results Using the Full Model
The default initial conditions for many of the simulations are shown in Table 3,
with all unlisted species set to zero molecules. Typical simulations were run for 10,000
seconds (2.7 hours) and solutions result in the time dependence of all species and reaction
fluxes. To simulate the acute exposure of cultured human (HBEC) cells to
benzo(a)pyrene (B(a)P), a transcriptional activator of LINE-1, we performed a parameter
sweep that varied the copy number of initial LINE-1 mRNA from 0 to 100,000 in decade
steps. Here, the assumption was that an acute exposure to various doses of the
carcinogen result in transient expression of LINE-1 mRNA and subsequent increases in
copy number. The simulation indicated that there is a definite threshold where the copy
number of LINE-1 DNA transitions from no change, then to a modest increase and
eventually, at 100k copies of mRNA, the LINE-1 DNA copy number falls into a positive
feedback loop, overwhelming the cellular defenses, resulting in an exponential increase.
Figure 25 shows the time evolution of LINE-1 DNA and cytoplasmic mRNA
count for simulations having 100, 10,000 and 100,000 initial copies of LINE-1 mRNA in
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Table 3 A list of typical initial conditions for the simulations. All other species are zero.
the nucleus. In the top row of the figure, one can see that the number of DNA copies

Species

Structure

Depiction

Clamped

Initial
Condition

RISC_Cyt_Unbound

Cytoplasm

No

1000
[molecules]

MOV10_Zap_Cyt_Ubound

Cytoplasm

Yes

1000
[molecules]

L1mRNA

Nucleus

No

0
[molecules]

L1DNA

Nucleus

No

100
[molecules]

Exportin_Nuc_Unbound

Nucleus

No

1000
[molecules]

Dicer_Cyt_Unbound

Cytoplasm

No

1000
[molecules]

increased by only one when the initial number of nuclear LINE-1 mRNA is only 100. In
the top right, the LINE-1 mRNA in the cytosol first rises to about 39 copies but quickly
falls to a stable basal level of 5-20 copies. In the center row, corresponding 10,000 initial
mRNA copies, the LINE-1 DNA copy number rises to 135 and then stabilizes by the end
of the simulation. Similarly, the LINE-1 mRNA in the cytosol first rapidly rises and once
again, drops to a basal level of 15-20 copies by the end of the simulation. Finally, in the
bottom row with an initial nuclear LINE-1 mRNA count of 100,000, the growth of both
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DNA and RNA becomes exponential causing the simulation to fault out before reaching
the 10,000 second end point. It is interesting to note that only in the last case of 100,000
LINE-1 mRNA copies does there seem to be any role for RISC degradation or
sequestration.

Figure 25 Evolution of LINE-1 DNA and cytoplasmic mRNA for different initial
numbers of nuclear LINE-1 mRNA. The various numbers of initial nuclear mRNA
model various degrees of LINE-1 DNA activation after acute exposure to
carcinogens.
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In a second set of simulations the role of the transcription rate of LINE-1 mRNA
was explored as a proxy for epigenetic dysregulation of LINE-1 due to carcinogen
exposure. The constant, Kf_Make_L1mRNA, was varied from 0.0001 s-1 to 1.0 s-1 in
decade steps and the model run for 10,000 seconds. Again, the model showed a distinct
threshold for the growth in LINE-1 DNA copy number between 0.01 s-1 and 0.1 s-1 and

Figure 26 The influence of mRNA transcription rate on LINE-1 mRNA copy number.
In the top graph, the amount of mRNA in the cytoplasm remains roughly constant at a
mRNA synthesis rate of 0.01 s-1 but begins to grow exponentially when the rate reaches
a threshold of 0.1 s-1 as shown in the lower graph.
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similarly the copy number of LINE-1 mRNA shows threshold behavior as illustrated in
Figure 26. As in the previous case where the initial number of LINE-1 mRNA was
varied, the role of RNAi and sequestration is minimal compared to general RNAse
activity in regulating LINE-1 mRNA. Indeed, in all cases where the LINE-1 mRNA
creation rate was varied, RNAi showed no LINE-1 mRNA degradation events even after
the rate of LINE-1 DNA creation began to feed forward exponentially. In contrast, the
stress granule and multivesicular body localization pathways began to be utilized at the
three highest values of the LINE-1 mRNA creation rates (i.e., 0.01 s-1, 0.1 s-1 and 1.0 s-1).
Given that the reported value of the transcription rate of ORF0 is approximately 1/10 the
transcription rates of the LINE-1 mRNA for ORF1 and ORF2[87], two rates of ORF0
creation were explored, 0.001 s-1 and 0.1 s-1. These values reflect the ORF1 and ORF2
creation rate extrema of 0.01 s-1 and 1.0 s-1 mentioned above. In both cases we did not
observe RISC degradation events over the model period of 10,000 seconds.
One element of the model that may be of concern when LINE-1 mRNA copy
number begins to get large, is the finite number of molecules such as Exportin, Mov10,
Dicer, and RISC with initial copy numbers of 1000. The model was thus also run with
constant copy numbers such that when a species, such as Exportin left the nucleus, a new
copy would be replenished to keep the copy number in the nucleus constant. The model
retained the same qualitative behavior and exhibited the same threshold values for
exponential growth as a function of the LINE-1 mRNA creation rate and were nearly
identical when we examined various initial values for the number of LINE-1 mRNA
copies.
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CHAPTER 5: 3-DIMENSIONAL VISUALIZATION OF
COMPUTATIONAL CELL BIOLOGY NETWORKS AND
SOLUTIONS USING VIRTUAL CELL AND OPENGRAPHITI

A. Summary
Two dimensional graphs are frequently used to represent networks of protein-protein
and enzyme-substrate interactions in computational cell biology networks. In most free
packages for simulating such networks, e.g., Virtual Cell, Cell Designer, and others, they
are visualized in 2-dimensions. At even moderate complexity these network maps
become difficult to read and understand. Separately, computer security firms have
developed 3-dimensional network visualizations that are used to track the health of
computer networks and potential threats. The Open DNS foundation has developed an
impressive open source 3-D network visualization system called OpenGraphiti that
includes a convenient python library (SemanticNet) for building graphs in the native
JSON format. We present a Python interface which maps biological networks generated
using the free Virtual Cell simulation package onto OpenGraphiti. Further, the software
allows one to visualize solutions of simulations from Virtual Cell, i.e., concentration as a
function of time, using the timeline feature of OpenGraphiti to change graph attributes
such as edge width or space activity of nodes.

73

B. Introduction
The study of cell biology is evolving from an approach that deconstructs and
examines the components of the cell to one that seeks to understand how these pieces
interact with one another, giving rise to what has been dubbed the ‘omics age [8, 9].
Understanding the complexity of these cellular systems necessitates computational
models and design software for their investigation. To that end several free packages
have been developed that enable simulation of metabolic pathways and other aspects of
cell function while simplifying the details of the underlying numerical analysis used to
solve for the temporal behavior of such systems. Two packages in particular are focused
on providing an integrated environment for cell biology simulations: Virtual Cell [19]
and Cell Designer [22]. Specifically, we focus on Virtual Cell in this work since as of
2022 it is under active development within the U.S. and Cell Designer has not been
updated since 2014.
Virtual Cell has a straightforward graphical user interface for designing reaction
pathways, specifying compartments, initial conditions, and reaction kinetics.

The

software also allows the user to choose among several types of models: either stochastic
or deterministic, and spatial which accounts for diffusion or non-spatial which assumes a
well-mixed system without diffusion.

In version 6.0 and above the authors have

introduced rule-based modelling that automates the task of determining the potential
variants of the model’s species, e.g. phosphorylation or complex formation. [21, 48].
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Figure 27 A 2-D visualization of a reaction network with 33 species and 67 reactions in
Virtual Cell
An important element of the software allows visualization of reactions and
complex formation as two-dimensional network graphs. An example of Virtual Cell’s
network representation is shown in Figure 27 for a network that describes how 4 separate
proteins and protein complexes join to form an epigenetic multimer. Reactions (which
include complex formation) are represented as square yellow nodes and species are
shown as green circular nodes. The complex DP1_E2F_Rb has 3 different
phosphorylation states and the SWI_SNF complex has one, as a result the model has 33
species and 67 reactions. As one can see from the figure, even this relatively simple
model becomes difficult to read and understand as this results in a nonplanar graph (that
is, one that cannot be represented in 2-dimensions without an edge crossing).
We present a Python based interface that connects native Virtual Cell files
(VCML, an XML dialect) to freeware 3-dimensional graph software called OpenGraphiti
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[124]. Originally developed by the Open DNS group in 2014 for tracking security threats
on computer networks, OpenGraphiti provides an aesthetically pleasing interface that
allows users to view the data set from any angle and orientation, it further allows one to
modify node and edge visualization parameters to suit their application. A second Python
script was also introduced that maps solutions generated in Virtual Cell in the form of
concentration as a function of time to graph parameters such as edge width and node
“activity”. The solution is then visualized in OpenGraphiti using the timeline feature.

C. Methods
Virtual Cell is a flexible and easy
to use tool that allows simulation of
biological systems that include mass
action kinetics, diffusion, membrane
transport, and multiple compartments. In
general models may be produced in two
basic modes: spatial and non-spatial with
additional options to use stochastic or
deterministic algorithms. For example, in
3-dimensional stochastic models the
software transparently implements a full
Monte Carlo based solution. Another
valuable feature implemented in Virtual

"nodes": [
{
"key val": "87732854",
"og:space:color": 1.0, 0.0, 0.0, 1.0],
"og:space:icon": "shapes/star",
"label": "Reaction4",
"og:space:activity": "0",
"type": "Reaction",
"id": "4f36756a2866451dbb2afe7fa1457642"
},
{
"key val": "87732867",
"og:space:color": [1.0, 0.0, 0.0, 1.0],
"og:space:icon": "shapes/star",
"label": "Reaction8",
"og:space:activity": "0",
"type": "Reaction",
"id": "7cf1037de1884268b0869679e94ea117"
}
…
"edges": [
{
"src": "4f36756a2866451dbb2afe7fa1457642",
"dst": "f679d56aa6b84a3cba398efa9c063c71",
"space:width": 0.1,
"id": "f79bfa05239e4626a4972b174fa41347",
"space:activity": 0.4
},
{
"src": "7cf1037de1884268b0869679e94ea117",
"dst": "ee45769bf62b4aab936c6ab0b7a8bea8",
…

Cell is the ability to import models via the Figure 28 Structure of a OpenGraphiti
formatted JSON file produced from the
Virtual Cell’s native *.VCML
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Systems Biology Markup Language (SBML) – a widely used, software independent
standard for sharing biological models that gives users access to hundreds of annotated
databases. Despite these capabilities, Virtual Cell currently has several noteworthy
limitations: species have no spatial extent, there is no easy way to represent the
interaction of proteins with DNA or genes, and it is limited to a static 2-dimensional
representation of network interactions.
The native file format for Virtual Cell (*.VCML) supports a complete description
of the species, reactions, kinetic equations, associated constants, cellular compartments,
and description of the mathematical simulations contained within a particular model.
Unfortunately, the actual solutions are not stored in the VCML. Instead, solutions must
be exported by copying the data from the spreadsheet view using the “copy all” command
available via a right click.
Semantic Net is a small Python library based on a graph library called NetworkX
(available on github) that allows data sets to be prepared in OpenGraphiti’s native JSON
(Java Script Object Notation) format. In addition to the basic creation of nodes and edges,
it includes a capability to create a timeline; a feature that allows the time variation of
network properties. The library also implements methods for sorting and searching lists
of nodes and edges for any property, whether intrinsic or user defined. It also supports
logical operations between graphs such as intersection, difference, and union.
OpenGraphiti is open source, written in C++ and capable of being compiled on
OSX and Linux. An example of the JSON text file format generated from the VCML is
shown in Figure 29. It consists of 3 main sections: a list of nodes, a list of edges and
optional timeline data (not shown in the figure). Nodes contain: “key val” a unique
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identifier from VCell, "og:space:color" which specifies red, green, blue and transparent
color values, and “og:space:icon” which determines the type of icon used to represent
the node, "label" is unique name imported from VCell, “og:space:activity” determines the
rate of expansion for an animated expanding circle around the node, the “type” delimiter
specifies whether the node represents a reaction or species, and finally the “id” is a
universally unique identifier (UUID) generated by SemanticNet. The edges contain: the
UUID’s of the source and destination nodes, "space:width" which specifies the line width
of the edge and has a value between 0 and 1, an “id” which is a UUID for the edge, and
"space:activity" with values from 0 to 1 which specifies the rate at which an animated
point of light travels the edge from source to destination.
Two Python scripts were implemented in this work with Python 2.7.3 on Linux
Ubuntu 14.04 that allow interfacing Virtual Cell networks and solutions to OpenGraphiti.
The first titled VCML_JSON_Converter_v2.5.py is used only for converting networks to
OpenGraphiti compatible JSON format with the intent to display static graphs. As in
Virtual Cell the resulting bionetwork is represented as a graph containing species and
reaction nodes with edges linking them. The command line for
VCML_JSON_Converter_v2.5.py is:
$ VCML_JSON_Converter_v2.5.py <vcell_file.VCML> <o_g_file.JSON>
The second script titled VCML_JSON_Converter_v2.6.3.py is used for
converting networks and native Virtual Cell solutions into a timeline for OpenGraphiti
display. Time dependent representations were visualized using the timeline feature to
change various aspects of the graphs based on the simulation results imported from
Virtual Cell. This was implemented in the visualization for each time dependent species
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and reaction rate in the model solution. Each data set was normalized over time and then
mapped to the edge width, representing species concentration, or node activity,
representing flux through reaction nodes. To increase the contrast between species
whose values vary but do not reach zero and those who span the whole range from 0 to 1,
the minimum values were modified to go through zero before normalization unless the
value is constant throughout the time-course of the solution. In those cases, the value is
set to one.
The command line for VCML_JSON_Converter_v2.6.3.py is:
$ VCML_JSON_Converter_v2.6.3.py <vcell_file.VCML> <solution_file.CSV>
<o_g_file.JSON>
Where <vcell_file.VCML> contains a single compartment Virtual Cell network,
<o_g_file.JSON> is the output file name, and <solution_file.CSV> is a comma separated
value file generated by copying the solution file data from Virtual Cell into a spreadsheet
program.

D. Results
An example of visualizing the same bionetwork from Figure 27 in OpenGraphiti
imported from Virtual Cell is shown in Figure 29. A more dynamic view is presented in
supplementary video 1. It illustrates a rendering of a small fraction of the retinoblastoma
network imported by hand from the Curie database [125]. The network contains 33
species nodes and 67 reaction nodes. It symbolizes a nonspatial model that can be readily
solved via 1st order mass action kinetics.
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Figure 29 A visualization of the same reaction network in OpenGraphiti in 3 dimensions.
See supplementary video 1 for a dynamic view.
OpenGraphiti allows for several display options for node (shapes, colors,
diameters) and edges (line weight, line type, color) and includes options for animating
each with a time dependent data set. When the program starts, a repulsive force field is
applied to the nodes which helps to spatially organize the system making it readable. The
rate at which the system evolves can be set within OpenGraphiti via a “temperature”
setting.
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Figure 30 Two-dimensional view of a simple cell cycle network in Virtual Cell
To demonstrate visualization of a time dependent data set in OpenGraphiti, a
system modeling the cell cycle was simulated in Virtual Cell [1]. The 2-dimensional
representation of the reaction network from Virtual Cell is shown in Figure 30. In the
model, “Y” corresponds to the protein cyclin, and it is generated de novo from the node
“EmptySet”. It may decompose before any further reactions as denoted by the reaction
returning it to the “EmptySet” or it may go on to react with the phosphorylated CDC2
protein, “CP”, to form a phosphorylated complex labeled “pM”. The phosphate may then
be removed by a catalytic enzyme “CT” to form the species “M” which symbolizes the
maturation promoting factor (MPF). Above a critical value, the MPF causes cellular
division but also degrades to leave a CDC2 and a phosphorylated cyclin protein that is
degraded back to the empty set.
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Figure 31 The time dependent solution to a model of the cell cycle from [1].
This simple system with physiological reaction constants and proper initial
conditions produces an oscillatory behavior in the concentration of several species that
models a cell undergoing a sequence of cell divisions. See Figure 31. A screen shot of
the model represented in OpenGraphiti is shown in Figure 32, however the dynamic
representation of the solution showing the animated graph edges can be found in
supplemental video 2 and video 3.
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Figure 32 3-Dimensional view of the cell cycle reaction network viewed in
OpenGraphiti. An animation of the solution to the time dependent concentration
represented by animated edges on the graph is shown in supplemental video 2 and video
3.
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CHAPTER 6: CONCLUSION
Previous experiments have demonstrated that the time course of LINE-1
activation upon exposure to B(a)P in HBEC lines peaks at 12 hours and returns to
baseline after 48 hours[105]. The present model shows similar behavior, where the
sweep of initial LINE-1 mRNA count (Figure 25) shows that typical cellular defenses can
prevent the uncontrolled proliferation of LINE-1 up to a certain critical load of initial
mRNA. Unlike the findings derived from experimental data, the kinetics of the model
are faster and show that the mRNA count drops within the first 100 seconds to a basal
level for all but the largest values of mRNA. This is likely due to our qualitative estimate
of many model parameters such as LINE-1 transcription and translation rates, nuclear
transport kinetics for species, LINE-1 ORF protein-RNA binding kinetics and RNase
kinetics. Additionally, damage to the epigenetic regulators is modeled as a one-time
increase in the number of LINE-1 mRNA copies where it would be more accurate to
model these effects with an empirically informed, time varying LINE-1 mRNA
transcription rate. The model also does not include LINE-1 catalyzed proliferation of the
far more numerous, non-autonomous retroelements or Short Interspersed Nuclear
Elements (SINEs). RNA from SINEs may act as a sink for ORF2p and other components
of cellular post transcriptional suppression, thus slowing the dynamics of LINE-1.
In the case of simulations that explored the creation rate of LINE-1 mRNA, the
model once again exhibited threshold behavior above which the feed-forward loop of
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LINE-1 results in exponential growth of its mRNA and DNA copy number. Clearly, the
uncontrolled growth of these factors is not physical and would be limited by the
availability of cellular resources such as nucleotides, amino acids, and tRNA. The model
would be improved by including other sources of siRNA such as non-autonomous copies
of LINE-1 with functional antisense ORF0 or other endogenous siRNAs.[86] Further,
the utility of this model would be greatly enhanced if the epigenetic mechanisms
controlling LINE-1 expression were developed to reflect histone modifications, DNA
methylation and the role of the PIWI system.
One interesting consequence that is evident from the model architecture is that
once the LINE-1 mRNA is bound by ORF1p or ORF2p, translation stops as ribosomes
are no longer able to bind the mRNA. This finding calls for further evaluation in light of
studies by Alisch et al.[126] implicating an unconventional translation/re-initiation
pathway for L1 translation, wherein multiple ORF1p molecules are translated from and
coat a single L1 mRNA molecule. In their study, however, inhibition of translocation of
scanning ribosomes was shown to reduce ORF2p synthesis, a finding consistent with our
model. In discussing this work, Dmitriev et al.[127] noted that the start of translation of
ORF2p was selected by an unconventional mechanism of reinitiation that did not involve
an internal ribosomal entry site, with procession of the ribosomal complex interrupted by
the presence of ORF1p or ORF2p on Line-1 mRNA. Additionally, our model suggests
that ORF1p and ORF2p may inhibit RNAi by binding to their respective sites when
LINE-1 mRNA is complexed with ORF0 mRNA to prevent Dicer loading. This
protective role for ORF1p against other degradation pathways has been confirmed
experimentally.[123] The model further showed that the RNAi pathway, using
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empirically derived reaction constants, and the antisense ORF0 RNA, did not play a
significant role in decreasing the rate of retrotransposition. Thus, the model does not
explain empirical observations showing that transcription of ORF0 mRNA increases
retrotransposition. Given that the ORF0 protein is not addressed in the model, future
work should include definitive roles for ORF0 in the life cycle of LINE-1. Additionally,
the number of RISC and DICER molecules is set to a constant, while the relevant
molecules would likely be subject to positive regulation as the pathway is utilized. There
may also be siRNAs and piRNAs that interact with LINE-1 mRNA to yield processing in
RISC and the model should be refined in the future to reflect these factors[87].
Furthermore, experimentally there is a complex relationship between the 5’ antisense
RNA, L1-ORF1p, Argonaut proteins and siRNA-mediated regulation of LINE-1[128]. In
the same study, the authors demonstrated that not only does the antisense RNA reduce
sense 5’ UTR expression, but that L1-ORF1p directly binds to Argonaut proteins- even
without RNA as a mediator. Future models should include these interactions to form a
more complete picture of LINE-1 dynamics.
Unlike the RNAi pathway, those involving sequestration to multi-vesicular bodies
and stress granules were utilized when LINE-1 mRNA creation rates were 0.01 s-1 and
above. It seems that these metabolically costly pathways only become important as the
RNase within the cytosol becomes overwhelmed. The current instance of the model
lumps together several independent pathways related to RNP, RNA and protein
sequestration into two broad categories: multivesicular bodies and stress granules using
only a single protein as a placeholder for a far more complex group of processes. As
such, this system should be represented with far more fidelity in future work. As noted
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earlier, LINE-1 is often activated in cancer cells, although the exact relationship between
cancer and retrotransposon activity has not been fully elucidated. This is particularly
relevant in trying to elucidate the role of LINE-1 laden exosome formation in cancer and
studies of the role of processing bodies in the formation of LINE-1 RNPs. As genomic
databases continue to expand, these data can be used to refine the model by exploring
critical genomic and epigenomic interactions between cancer genes and LINE-1. Several
open questions were illuminated in our study. For example, what happens to the
components of the LINE-1 RNP after reverse transcription in the nucleus? Particularly, if
ORF2p does not degrade LINE-1 RNA upon reverse transcription[83, 121], why is it that
new RNP’s do not form in the nucleus? Experimentally, this does not seem to occur
given the lack of ORF1p and ORF2p accumulation in the nucleus and there is speculation
that RNPs may only form in processing bodies[104]. Given that the formation of LINE-1
mRNA complexes with ORF1p and ORF2p is likely to block RNAi and sequestration
into stress granules, it might be interesting to experimentally explore delivery of short
RNA sequences that are homologous to LINE-1mRNA to block the interactions. Finally,
some studies suggest that LINE-1 proliferation is closely tied to the cell cycle and
dissolution of the nuclear membrane[129], thus future models should explore this
relationship.
Currently all software packages used to model metabolisms and networks of
chemical reactions in biological systems represent those networks as 2 dimensional
graphs. However, these systems rapidly become complex and difficult to visualize. By
displaying graphs of these systems in a 3-D interactive environment it is much easier to
gain an understanding of the network. Further, by animating aspects of the system’s
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graph we demonstrated a novel method of displaying reaction rates through each edge of
the graph. Generally, this work demonstrates a proof of principle for interfacing a
computational biology package to 3-dimensional graph visualization software using
readily available software tools and Python programing.
Future versions of software for computational cell biology would benefit by
adding 3-D views to display both the reaction networks and the computational solutions.
Three-dimensional visualization would lend itself well to working in virtual reality and
augmented reality. Eventually, editing and network definition could be performed in this
three-dimensional representation.
Continued refinement of the LINE-1 computational model has the potential to
elucidate its role in several biological contexts. As the work of Chapter 4 [120] reflected,
several avenues for improvement to the model are clear.

The model should include a

more detailed look at the pathways leading to exosome formation as they are informed by
recent experiments. A model that includes a representation of LINE-1 epigenetics would
facilitate exploration of its activation under various environmental insults. The addition
of data from the cancer genomes project such as LINE-1 mRNA, proteins, and
sequencing data to detect translocation events will allow direct comparison of the model
to experiment and aid its subsequent refinement. In a recent publication by Nurk et. al.
titled “The complete sequence of a human genome” [69] and a companion paper titled
“From telomere to telomere: The transcriptional and epigenetic state of human repeat
elements“ [130] the highly repetitive regions of the human genome laden with
transposable elements has been mapped in unprecedented detail. By using long read
sequences enabled by Nanopore technologies combined with time dependent maps of
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methylation and measurements of transcription rates the authors have produced a data set
that determined the sequence, copy number variation, and transcription over the cell
cycle. Future investigations with the LINE-1 computational model should be informed
by such data sets and are poised to profoundly deepen our understanding of its biological
role.
The tools of modern biotechnology continue to evolve at a breakneck pace with
both a focus on the collection of vast arrays of data and its distillation. The techniques
and associated hardware of molecular biology continue their close collaboration to bring
new experimental breakthroughs while driving costs down. Today cutting-edge
experiments involve simultaneous DNA and mRNA sequencing, CHiP-seq, and
proteomics, from individual samples, in some cases at the single cell level. One
important example is to be found at the National Cancer Institute’s Cancer Genome Atlas
which has so far scrutinized over 20,000 biopsies from 33 types of cancer. The publicly
available data set includes genomics, transcriptomic, epigenetic, and even proteomic data.
Although these data and similar databases have already made an impact on the course of
cancer research and facilitated continued discovery of new pathways and genes, much
has yet to be done. New software tools are clearly integral to exploiting the torrent of
data and aim at improved sequencing, deep learning systems that ferret out subtle
relationships, visualization, and simulation to name a few.
The future of biological modelling will likely integrate the diverse datasets of the
omics revolution, presumably in a transparent, more automated way. For example, as
understanding of the relationship between DNA sequence and function deepens it is
reasonable to expect models to automatically introduce function given the sequence as
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opposed to the current practice of manually introducing each protein, defining a function,
and inserting the kinetics. In such systems it will be important to add the role of
epigenetic transcriptional regulation from promoters to histone modifications to allow full
execution of DNA’s genetic programs. Models that incorporate an understanding of how
the genomic program is read and played will lead quite naturally to insights related to cell
identity, differentiation, and eventually to a deeper understanding of developmental
biology. Specifically, as sheer computational power continues to increase, larger and
larger systems will become tractable eventually leading from sub cellular systems to
whole cells, tissues, organs, and even whole organisms. These computational models
will likely evolve to enable engineering of pathways, study of organism wide disease
states, and even to engineering whole organism development.
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